<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AIFM2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>AIFM2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9BRQ8" target="_blank" class="term-link">
                        Q9BRQ8
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "AIFM2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9BRQ8" data-a="DESCRIPTION: FSP1 (Ferroptosis Suppressor Protein 1, formerly A..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>FSP1 (Ferroptosis Suppressor Protein 1, formerly AMID/PRG3) is an FAD-dependent, N-myristoylated membrane oxidoreductase that functions as a major glutathione-independent suppressor of ferroptosis. FSP1 catalyzes the NAD(P)H-dependent reduction of ubiquinone (CoQ10) to ubiquinol and vitamin K to its hydroquinone form (VKH2), both of which act as potent radical-trapping antioxidants to prevent phospholipid peroxidation at cellular membranes. FSP1 operates in parallel to GPX4 as a second major defense against ferroptosis. N-myristoylation targets FSP1 to the plasma membrane and lipid droplets where it performs its anti-ferroptotic function. The original characterization as a pro-apoptotic factor (AMID) from early studies has been largely superseded by the discovery of its primary role in ferroptosis suppression.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 is now recognized as the primary glutathione-independent ferroptosis suppressor, acting in parallel to GPX4 (PMID:31634899, PMID:31634900). This function was definitively established in 2019 and represents the core biological role of the protein. The IBA annotation from phylogenetic inference is consistent with extensive experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the primary biological function of FSP1. Multiple high-quality studies demonstrate that FSP1 suppresses ferroptosis by regenerating ubiquinol and vitamin K hydroquinone as radical-trapping antioxidants (PMID:31634899, PMID:31634900, PMID:35922516).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the flavoprotein apoptosis-inducing factor mitochondria-associated 2 (AIFM2) is a previously unrecognized anti-ferroptotic gene</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AIFM2/AIFM2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">renamed ferroptosis suppressor protein 1 (FSP1) for its role in suppressing ferroptosis independently of GPX4</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/39313331" target="_blank" class="term-link">
                                        PMID:39313331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">temsirolimus sensitized liver cancer cells to ferroptosis by directly binding to and inhibiting ferroptosis suppressor protein 1 (FSP1) enzyme</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38514855" target="_blank" class="term-link">
                                        PMID:38514855
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The RNF126-FSP1-CoQ10 pathway plays a pivotal role in suppressing phospholipid peroxidation and ferroptosis both in vivo and in vitro</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008637" target="_blank" class="term-link">
                                    GO:0008637
                                </a>
                            </span>
                            <span class="term-label">apoptotic mitochondrial changes</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0008637" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation derives from the early characterization of AIFM2 as AMID in 2002 (PMID:11980907), before the discovery of ferroptosis and FSP1&#39;s primary role. UniProt notes explicitly: &#34;Conflicting data exist on the pro-apoptotic function of the protein. It was initially claimed that overexpression of FSP1 induces caspase-independent apoptosis, but new evidence disputes this function.&#34;
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While overexpression studies showed apoptotic phenotypes (PMID:11980907), this likely represents an artifact of overexpression or a minor function. The primary function of FSP1 is now firmly established as ferroptosis suppression. However, some literature suggests FSP1 may have context-dependent roles in cell death pathways, so complete removal is not warranted.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Overexpression of AMID induced cell death with characteristic apoptotic morphology</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031966" target="_blank" class="term-link">
                                    GO:0031966
                                </a>
                            </span>
                            <span class="term-label">mitochondrial membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0031966" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Early studies localized AMID to mitochondria (PMID:11980907), hence the name &#34;mitochondrion-associated.&#34; However, the current understanding is that FSP1 primarily localizes to the plasma membrane and lipid droplets via N-myristoylation, where it performs its anti-ferroptotic function (PMID:31634899, PMID:31634900). The mitochondrial localization may represent a minor pool or overexpression artifact.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While some studies showed mitochondrial localization, the primary functional location of FSP1 is at the plasma membrane and lipid droplets. The N-myristoylation that targets FSP1 to membranes is essential for its anti-ferroptotic function. Mitochondrial association may be context-dependent or represent a minor pool.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">myristoylation recruits FSP1 to the plasma membrane where it functions as an oxidoreductase that reduces coenzyme Q10</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043065" target="_blank" class="term-link">
                                    GO:0043065
                                </a>
                            </span>
                            <span class="term-label">positive regulation of apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0043065" data-r="GO_REF:0000033" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation from phylogenetic inference reflects the early AMID characterization (PMID:11980907, PMID:12135761). UniProt explicitly notes conflicting data on the pro-apoptotic function. The overexpression-based pro-apoptotic phenotype has not been validated as a physiological function, and FSP1&#39;s primary role is now established as ANTI-ferroptotic (which prevents a form of cell death).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The pro-apoptotic function was based on overexpression studies from 2002 before ferroptosis was discovered. Current understanding is that FSP1 prevents cell death by suppressing ferroptosis. The apoptotic function is disputed in the literature and likely represents an overexpression artifact.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Overexpression of AMID induced cell death with characteristic apoptotic morphology</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005737" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 is present in the cytoplasm (PMID:12135761, UniProt confirmed). This is consistent with its role as a soluble oxidoreductase that can be recruited to membranes via N-myristoylation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasmic localization is well-supported and represents the non-membrane-bound pool of FSP1. Multiple studies confirm cytoplasmic presence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12135761" target="_blank" class="term-link">
                                        PMID:12135761
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PRG3 localizes in the cytoplasm</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004174" target="_blank" class="term-link">
                                    GO:0004174
                                </a>
                            </span>
                            <span class="term-label">electron-transferring-flavoprotein dehydrogenase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0004174" data-r="GO_REF:0000033" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This GO term (GO:0004174) refers to the specific activity of electron transfer from electron-transferring flavoprotein (ETF) to ubiquinone in the mitochondrial electron transport chain. FSP1 is NOT part of the mitochondrial electron transport chain and does not interact with ETF. FSP1 is a CoQ/vitamin K reductase that acts at the plasma membrane, not in mitochondrial respiration.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0004174 is the incorrect term for FSP1&#39;s activity. FSP1 reduces ubiquinone directly using NAD(P)H, not via ETF. The correct term is GO:0016655 &#34;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor&#34; which precisely describes FSP1&#39;s catalytic mechanism.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">FSP1 catalyses the regeneration of CoQ10 using NAD(P)H</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050660" target="_blank" class="term-link">
                                    GO:0050660
                                </a>
                            </span>
                            <span class="term-label">flavin adenine dinucleotide binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0050660" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 binds a modified FAD cofactor (6-hydroxy-FAD) non-covalently (PMID:15958387). Structural studies of chicken FSP1 revealed the carboxy-terminal domain mediates functional dimerization and the formation of two active sites on either side of the FAD (PMID:37739943). The 6-hydroxy-FAD is both an active cofactor and itself an anti-ferroptotic compound.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> FAD binding is a core feature of FSP1 required for its oxidoreductase activity. The protein binds 6-hydroxy-FAD as its cofactor. Structural studies confirm the FAD-binding domain as essential for the homodimer assembly and catalytic activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                                        PMID:15958387
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID binds 6-hydroxy-FAD (a cofactor that accumulates only adventitiously and at low abundance in other flavoprotein enzymes) to form a stoichiometric cofactor.protein complex</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/37739943" target="_blank" class="term-link">
                                        PMID:37739943
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the carboxy-terminal domain is crucial for the catalytic activity and ferroptosis inhibition of FSP1 by mediating the functional dimerization of FSP1, and the formation of two active sites located on two sides of FAD</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                                    GO:0003677
                                </a>
                            </span>
                            <span class="term-label">DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0003677" data-r="GO_REF:0000043" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> DNA binding was demonstrated biochemically in PMID:15958387, showing non-sequence specific binding. However, this is not considered the core function of FSP1 and its physiological relevance is unclear. UniProt notes this activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While DNA binding was demonstrated in vitro, its physiological relevance is unclear. The primary function of FSP1 is as a membrane oxidoreductase suppressing ferroptosis, not DNA binding.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                                        PMID:15958387
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID is a DNA-binding protein that lacks apparent DNA sequence specificity</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005634" data-r="GO_REF:0000120" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Nuclear localization was reported in the context of oxidative stress signaling (PMID:26689472). Upon oxidative stress, FSP1 modified by 4-hydroxynonenal translocates to the nucleus. This is not the primary localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nuclear localization occurs under specific stress conditions and is not the primary functional location. The plasma membrane and lipid droplets are the primary sites of FSP1 activity.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005737" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate of earlier cytoplasm annotation. Cytoplasmic localization is confirmed.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasmic localization is well-supported by multiple studies.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                    GO:0005811
                                </a>
                            </span>
                            <span class="term-label">lipid droplet</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005811" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 localizes to lipid droplets via N-myristoylation (PMID:31634900, PMID:14741744). This is a core functional localization site.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Lipid droplet localization is a primary site where FSP1 performs its anti-ferroptotic function by regenerating reduced quinones to prevent lipid peroxidation.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005886" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Plasma membrane is the PRIMARY functional location of FSP1 (PMID:31634900). N-myristoylation targets FSP1 to the plasma membrane where it reduces CoQ and vitamin K to suppress ferroptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core localization site for FSP1 function. The plasma membrane is where FSP1 regenerates ubiquinol and VKH2 to act as radical-trapping antioxidants.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">myristoylation recruits FSP1 to the plasma membrane where it functions as an oxidoreductase that reduces coenzyme Q10</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016491" target="_blank" class="term-link">
                                    GO:0016491
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016491" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 is indeed an oxidoreductase - this is its core molecular function. However, this term is very general; the more specific term GO:0016655 is preferable.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While correct, this general term is subsumed by the more specific GO:0016655 which precisely describes FSP1&#39;s NAD(P)H-quinone reductase activity. Acceptable as a broader classification.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0022904" target="_blank" class="term-link">
                                    GO:0022904
                                </a>
                            </span>
                            <span class="term-label">respiratory electron transport chain</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000108
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0022904" data-r="GO_REF:0000108" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is INCORRECT. FSP1 is NOT part of the mitochondrial respiratory electron transport chain. FSP1 reduces quinones at the plasma membrane, not in mitochondrial respiration. This appears to be an erroneous inference from the electron-transferring-flavoprotein dehydrogenase activity annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> FSP1 does not function in the respiratory electron transport chain. Its primary role is reducing ubiquinone and vitamin K at the plasma membrane to suppress ferroptosis, which is entirely distinct from mitochondrial respiration. This is a false annotation that should be removed.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">myristoylation recruits FSP1 to the plasma membrane where it functions as an oxidoreductase that reduces coenzyme Q10</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031966" target="_blank" class="term-link">
                                    GO:0031966
                                </a>
                            </span>
                            <span class="term-label">mitochondrial membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0031966" data-r="GO_REF:0000120" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate of earlier mitochondrial membrane annotation. See previous review.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Mitochondrial membrane is not the primary functional location; plasma membrane and lipid droplets are. May represent minor pool or legacy annotation.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005515" data-r="PMID:32296183" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is from a high-throughput binary interactome study. &#34;Protein binding&#34; is uninformative per GO curation guidelines.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 &#34;protein binding&#34; is considered too vague and uninformative. Per curation guidelines, more specific binding terms should be used when available. This annotation does not tell us about FSP1&#39;s actual function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                                        PMID:32296183
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Here we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation - negative regulation of ferroptosis by electronic inference. Consistent with experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Ferroptosis suppression is the core biological function of FSP1. Electronic inference is consistent with extensive experimental evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1900407" target="_blank" class="term-link">
                                    GO:1900407
                                </a>
                            </span>
                            <span class="term-label">regulation of cellular response to oxidative stress</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:1900407" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 regulates oxidative stress response through its role in preventing lipid peroxidation. This is consistent with its function as a radical-trapping antioxidant regenerator.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> By regenerating ubiquinol and VKH2, FSP1 prevents lipid peroxidation and modulates cellular response to oxidative stress.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000052
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005829" data-r="GO_REF:0000052" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cytosolic localization confirmed by immunofluorescence (HPA). Consistent with FSP1 being a soluble protein that can be recruited to membranes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytosolic localization is well-supported and represents the non-membrane-bound pool of FSP1.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/37957306" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:37957306
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Integrated chemical and genetic screens unveil FSP1 mechanis...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:37957306" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is the CORRECT and most specific molecular function term for FSP1. FSP1 reduces ubiquinone and vitamin K quinones using NAD(P)H as the electron donor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This precisely describes FSP1&#39;s core enzymatic activity demonstrated in multiple studies (PMID:31634899, PMID:31634900, PMID:35922516, PMID:37957306).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/37957306" target="_blank" class="term-link">
                                        PMID:37957306
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction of quinones</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042373" target="_blank" class="term-link">
                                    GO:0042373
                                </a>
                            </span>
                            <span class="term-label">vitamin K metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/36788244" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:36788244
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0042373" data-r="PMID:36788244" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 reduces vitamin K to its hydroquinone form (VKH2), which acts as a potent radical-trapping antioxidant. FSP1 is the warfarin-resistant vitamin K reductase (PMID:35922516).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Vitamin K reduction is a core enzymatic activity of FSP1, demonstrated both in vitro and in vivo. FSP1-mediated vitamin K reduction constitutes a non-canonical vitamin K cycle for ferroptosis suppression.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                                        PMID:35922516
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">was found to efficiently reduce vitamin K to its hydroquinone, a potent radical-trapping antioxidant and inhibitor of (phospho)lipid peroxidation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/36788244" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:36788244
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:36788244" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Ferroptosis suppression via vitamin K reduction pathway. Core function with direct experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function of FSP1 with direct experimental support.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/36788244" target="_blank" class="term-link">
                                        PMID:36788244
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ferroptosis suppressor protein 1 (FSP1), a ubiquinone oxidoreductase, is the enzyme responsible for vitamin K reduction in a warfarin-resistant manner</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/37957306" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:37957306
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Integrated chemical and genetic screens unveil FSP1 mechanis...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:37957306" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Additional experimental evidence for ferroptosis suppression function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function with direct experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/37957306" target="_blank" class="term-link">
                                        PMID:37957306
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction of quinones</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/37739993" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:37739993
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FSP1 oxidizes NADPH to suppress ferroptosis.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:37739993" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Core molecular function with experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity confirmed by direct assay.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/37739993" target="_blank" class="term-link">
                                        PMID:37739993
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">FSP1 oxidizes NADPH to suppress ferroptosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/39160155" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:39160155
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural insight into 6-OH-FAD-dependent activation of hFS...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:39160155" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Core molecular function demonstrated via structural studies showing 6-OH-FAD involvement.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity confirmed by structural analysis.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/39160155" target="_blank" class="term-link">
                                        PMID:39160155
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Human ferroptosis suppressor protein 1 (hFSP1), which utilizes 6-OH-FAD as the primary cofactor, prevents lipid peroxidation by oxidizing NAD(P)H</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:40233740
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ALDH7A1 protects against ferroptosis by generating membrane ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005886" data-r="PMID:40233740" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Plasma membrane localization confirmed by direct assay. This is a core localization site.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization for FSP1&#39;s anti-ferroptotic function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link">
                                        PMID:40233740
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ALDH7A1 promotes the membrane recruitment of FSP1</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634899
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FSP1 is a glutathione-independent ferroptosis suppressor.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:31634899" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is the landmark paper establishing FSP1&#39;s function as a CoQ reductase.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity from the discovery paper.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">FSP1 catalyses the regeneration of CoQ10 using NAD(P)H</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:40233740
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ALDH7A1 protects against ferroptosis by generating membrane ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:40233740" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Core molecular function with experimental evidence from ALDH7A1/FSP1 study.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity confirmed.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link">
                                        PMID:40233740
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ferroptosis suppressor protein 1 (FSP1) protects against this death by generating antioxidants, which requires nicotinamide adenine dinucleotide, reduced form (NADH) as a cofactor</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634899
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FSP1 is a glutathione-independent ferroptosis suppressor.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:31634899" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Landmark paper establishing FSP1 as a ferroptosis suppressor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function from the discovery paper.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the flavoprotein apoptosis-inducing factor mitochondria-associated 2 (AIFM2) is a previously unrecognized anti-ferroptotic gene</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:40233740
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ALDH7A1 protects against ferroptosis by generating membrane ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:40233740" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Ferroptosis suppression confirmed in ALDH7A1/FSP1 axis study.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link">
                                        PMID:40233740
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ferroptosis suppressor protein 1 (FSP1) protects against this death by generating antioxidants</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35922516
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A non-canonical vitamin K cycle is a potent ferroptosis supp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:35922516" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This paper demonstrates FSP1 reduces both ubiquinone and vitamin K using NAD(P)H.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity confirmed for both CoQ and vitamin K substrates.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                                        PMID:35922516
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ferroptosis suppressor protein 1 (FSP1), a NAD(P)H-ubiquinone reductase and the second mainstay of ferroptosis control after glutathione peroxidase-4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042373" target="_blank" class="term-link">
                                    GO:0042373
                                </a>
                            </span>
                            <span class="term-label">vitamin K metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35922516
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A non-canonical vitamin K cycle is a potent ferroptosis supp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0042373" data-r="PMID:35922516" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 is the warfarin-resistant vitamin K reductase in both the non-canonical (anti-ferroptotic) and canonical (coagulation) vitamin K cycles.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity with direct evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                                        PMID:35922516
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">FSP1 is the enzyme mediating warfarin-resistant vitamin K reduction in the canonical vitamin K cycle</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35922516
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A non-canonical vitamin K cycle is a potent ferroptosis supp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:35922516" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1-mediated vitamin K reduction constitutes a non-canonical vitamin K cycle that suppresses ferroptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                                        PMID:35922516
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The FSP1-dependent non-canonical vitamin K cycle can act to protect cells against detrimental lipid peroxidation and ferroptosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990748" target="_blank" class="term-link">
                                    GO:1990748
                                </a>
                            </span>
                            <span class="term-label">cellular detoxification</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35922516
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A non-canonical vitamin K cycle is a potent ferroptosis supp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:1990748" data-r="PMID:35922516" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> By regenerating radical-trapping antioxidants (ubiquinol, VKH2), FSP1 protects cells from lipid peroxidation, which can be considered a form of detoxification.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> FSP1&#39;s function in preventing lipid peroxidation represents cellular detoxification of lipid radicals.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                                        PMID:35922516
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">was found to efficiently reduce vitamin K to its hydroquinone, a potent radical-trapping antioxidant and inhibitor of (phospho)lipid peroxidation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005634" data-r="GO_REF:0000024" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Nuclear localization inferred from mouse ortholog. May occur under oxidative stress.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Not the primary functional location. Nuclear translocation may occur under specific stress conditions.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1900407" target="_blank" class="term-link">
                                    GO:1900407
                                </a>
                            </span>
                            <span class="term-label">regulation of cellular response to oxidative stress</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:1900407" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 regulates oxidative stress response through its anti-ferroptotic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Consistent with FSP1&#39;s role in preventing lipid peroxidation.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                    GO:0005811
                                </a>
                            </span>
                            <span class="term-label">lipid droplet</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634900
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005811" data-r="PMID:31634900" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Lipid droplet localization demonstrated in the FSP1 discovery paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization site for FSP1&#39;s anti-ferroptotic function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Together, these results indicate that myristoylation of FSP1 mediates its recruitment to LDs and the plasma membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634900
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005886" data-r="PMID:31634900" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Plasma membrane localization demonstrated in the FSP1 discovery paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Primary localization site for FSP1&#39;s anti-ferroptotic function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">myristoylation recruits FSP1 to the plasma membrane where it functions as an oxidoreductase that reduces coenzyme Q10</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38514855" target="_blank" class="term-link">
                                        PMID:38514855
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the deletion of RNF126 reduces the subcellular localization of FSP1 in the plasma membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006743" target="_blank" class="term-link">
                                    GO:0006743
                                </a>
                            </span>
                            <span class="term-label">ubiquinone metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634899
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FSP1 is a glutathione-independent ferroptosis suppressor.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0006743" data-r="PMID:31634899" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 reduces ubiquinone to ubiquinol, constituting involvement in CoQ metabolism.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological process - FSP1 regenerates ubiquinol at the plasma membrane.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the suppression of ferroptosis by FSP1 is mediated by ubiquinone (also known as coenzyme Q10, CoQ10): the reduced form, ubiquinol, traps lipid peroxyl radicals that mediate lipid peroxidation, whereas FSP1 catalyses the regeneration of CoQ10 using NAD(P)H</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006743" target="_blank" class="term-link">
                                    GO:0006743
                                </a>
                            </span>
                            <span class="term-label">ubiquinone metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634900
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0006743" data-r="PMID:31634900" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FSP1 as CoQ oxidoreductase - involvement in ubiquinone metabolism.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological process.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">myristoylation recruits FSP1 to the plasma membrane where it functions as an oxidoreductase that reduces coenzyme Q10 (CoQ) (also known as ubiquinone-10)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    GO:0016655
                                </a>
                            </span>
                            <span class="term-label">oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634900
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0016655" data-r="PMID:31634900" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Core molecular function from the companion FSP1 discovery paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634899
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FSP1 is a glutathione-independent ferroptosis suppressor.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:31634899" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Ferroptosis suppression demonstrated by mutant phenotype analysis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function with genetic evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                                        PMID:31634899
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AIFM2, which we renamed ferroptosis suppressor protein 1 (FSP1) and which was initially described as a pro-apoptotic gene11, confers protection against ferroptosis elicited by GPX4 deletion</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                    GO:0110076
                                </a>
                            </span>
                            <span class="term-label">negative regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31634900
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0110076" data-r="PMID:31634900" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Ferroptosis suppression demonstrated by mutant phenotype analysis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological function with genetic evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                                        PMID:31634900
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Together, these findings demonstrate that FSP1 is a strong suppressor of ferroptosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    GO:0005741
                                </a>
                            </span>
                            <span class="term-label">mitochondrial outer membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6791306
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005741" data-r="Reactome:R-HSA-6791306" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This Reactome annotation relates to TP53-mediated AIFM2 transcription in the context of cytochrome C release. The mitochondrial outer membrane localization derives from the original AMID characterization, but FSP1&#39;s primary functional location is now known to be plasma membrane and lipid droplets.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Not the primary functional location. The plasma membrane and lipid droplets are where FSP1 performs its core anti-ferroptotic function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043065" target="_blank" class="term-link">
                                    GO:0043065
                                </a>
                            </span>
                            <span class="term-label">positive regulation of apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11980907
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AMID, an apoptosis-inducing factor-homologous mitochondrion-...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0043065" data-r="PMID:11980907" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is from the original 2002 AMID characterization showing overexpression-induced apoptosis. UniProt explicitly notes conflicting data on this function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Based on overexpression studies before FSP1&#39;s primary function was known. Current consensus is that FSP1 suppresses cell death (ferroptosis) rather than promoting it. The pro-apoptotic function may be an artifact of overexpression.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Overexpression of AMID induced cell death with characteristic apoptotic morphology</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                    GO:0005615
                                </a>
                            </span>
                            <span class="term-label">extracellular space</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22664934" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22664934
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Comparison of tear protein levels in breast cancer patients ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005615" data-r="PMID:22664934" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is from a tear proteomics study comparing breast cancer patients to controls. Extracellular detection may represent secretion or cell lysis. This is not a primary functional location.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Detection in tear fluid does not indicate extracellular space is a primary functional location. May be due to cell lysis or non-specific secretion.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22664934" target="_blank" class="term-link">
                                        PMID:22664934
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Over 150 proteins in the tear fluid of CTRL and CA were identified</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008637" target="_blank" class="term-link">
                                    GO:0008637
                                </a>
                            </span>
                            <span class="term-label">apoptotic mitochondrial changes</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11980907
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AMID, an apoptosis-inducing factor-homologous mitochondrion-...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0008637" data-r="PMID:11980907" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> From the original AMID characterization. The pro-apoptotic function is disputed.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Legacy annotation based on overexpression studies. Not considered a core function based on current understanding of FSP1 as a ferroptosis suppressor.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID induces a novel caspase-independent apoptotic pathway</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                    GO:0005811
                                </a>
                            </span>
                            <span class="term-label">lipid droplet</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:14741744
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of major proteins in the lipid droplet-enrich...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005811" data-r="PMID:14741744" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Early identification of FSP1/AMID in lipid droplet proteomics from hepatocytes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Lipid droplet localization confirmed by multiple studies. Core localization site.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link">
                                        PMID:14741744
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">17 major proteins in the fraction were identified using nano LC-MS/MS techniques</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                                    GO:0003677
                                </a>
                            </span>
                            <span class="term-label">DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15958387
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The human apoptosis-inducing protein AMID is an oxidoreducta...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0003677" data-r="PMID:15958387" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> DNA binding demonstrated biochemically, but lacking sequence specificity. Physiological relevance unclear.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While demonstrated in vitro, DNA binding is not considered a core function of FSP1. Its physiological relevance is unclear.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                                        PMID:15958387
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID is a DNA-binding protein that lacks apparent DNA sequence specificity</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004174" target="_blank" class="term-link">
                                    GO:0004174
                                </a>
                            </span>
                            <span class="term-label">electron-transferring-flavoprotein dehydrogenase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15958387
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The human apoptosis-inducing protein AMID is an oxidoreducta...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0004174" data-r="PMID:15958387" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This term (GO:0004174) specifically refers to electron transfer from ETF to ubiquinone in the mitochondrial ETC. FSP1 does not interact with ETF and is not part of the respiratory chain. The correct term is GO:0016655.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0004174 is incorrect - FSP1 reduces quinones directly using NAD(P)H, not via ETF. Should be GO:0016655.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                                    oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                                        PMID:15958387
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">possesses NAD(P)H oxidase activity; and catalyzes NAD(P)H-dependent reduction of cytochrome c and other electron acceptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050660" target="_blank" class="term-link">
                                    GO:0050660
                                </a>
                            </span>
                            <span class="term-label">flavin adenine dinucleotide binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15958387
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The human apoptosis-inducing protein AMID is an oxidoreducta...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0050660" data-r="PMID:15958387" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> FAD binding (specifically 6-hydroxy-FAD) directly demonstrated biochemically.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core molecular function - FAD binding is essential for FSP1&#39;s oxidoreductase activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                                        PMID:15958387
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID binds 6-hydroxy-FAD (a cofactor that accumulates only adventitiously and at low abundance in other flavoprotein enzymes) to form a stoichiometric cofactor.protein complex</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/12135761" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:12135761
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A novel p53-inducible apoptogenic gene, PRG3, encodes a homo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005737" data-r="PMID:12135761" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cytoplasmic localization confirmed in the original PRG3 paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Well-supported localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12135761" target="_blank" class="term-link">
                                        PMID:12135761
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PRG3 localizes in the cytoplasm</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005739" target="_blank" class="term-link">
                                    GO:0005739
                                </a>
                            </span>
                            <span class="term-label">mitochondrion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11980907
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AMID, an apoptosis-inducing factor-homologous mitochondrion-...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005739" data-r="PMID:11980907" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mitochondrial localization from the original AMID paper. Current understanding indicates plasma membrane and lipid droplets are the primary functional sites.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While some mitochondrial localization was reported, the primary functional locations are plasma membrane and lipid droplets. The name &#34;AMID&#34; (mitochondrion- associated) reflects the original characterization but not current understanding.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescent staining and biochemical experiments indicated that AMID was co-localized with mitochondria</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    GO:0005741
                                </a>
                            </span>
                            <span class="term-label">mitochondrial outer membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11980907
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AMID, an apoptosis-inducing factor-homologous mitochondrion-...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005741" data-r="PMID:11980907" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mitochondrial outer membrane localization from original AMID paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Not the primary functional location based on current understanding.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescent staining and biochemical experiments indicated that AMID was co-localized with mitochondria</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11980907
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AMID, an apoptosis-inducing factor-homologous mitochondrion-...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9BRQ8" data-a="GO:0005829" data-r="PMID:11980907" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cytosolic localization confirmed.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytosolic localization is well-supported.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                                        PMID:11980907
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AMID lacks a mitochondrial localization sequence but shares significant homology with AIF and NADH oxidoreductases</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>FSP1 is the major glutathione-independent ferroptosis suppressor, operating in parallel to GPX4. Demonstrated by genetic deletion and overexpression studies in multiple cell types and in vivo models.</h3>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="FUNCTION: FSP1 is the major glutathione-independent ferropto..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016655" target="_blank" class="term-link">
                            oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0110076" target="_blank" class="term-link">
                                negative regulation of ferroptosis
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006743" target="_blank" class="term-link">
                                ubiquinone metabolic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042373" target="_blank" class="term-link">
                                vitamin K metabolic process
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                lipid droplet
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000024.md" target="_blank" class="term-link">
                            GO_REF:0000024
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000052.md" target="_blank" class="term-link">
                            GO_REF:0000052
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on curation of immunofluorescence data</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000108.md" target="_blank" class="term-link">
                            GO_REF:0000108
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic assignment of GO terms using logical inference, based on on inter-ontology links</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11980907" target="_blank" class="term-link">
                            PMID:11980907
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12135761" target="_blank" class="term-link">
                            PMID:12135761
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link">
                            PMID:14741744
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15958387" target="_blank" class="term-link">
                            PMID:15958387
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22664934" target="_blank" class="term-link">
                            PMID:22664934
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31634899" target="_blank" class="term-link">
                            PMID:31634899
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">FSP1 is a glutathione-independent ferroptosis suppressor.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31634900" target="_blank" class="term-link">
                            PMID:31634900
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35922516" target="_blank" class="term-link">
                            PMID:35922516
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A non-canonical vitamin K cycle is a potent ferroptosis suppressor.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36788244" target="_blank" class="term-link">
                            PMID:36788244
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37739993" target="_blank" class="term-link">
                            PMID:37739993
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">FSP1 oxidizes NADPH to suppress ferroptosis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37957306" target="_blank" class="term-link">
                            PMID:37957306
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/39160155" target="_blank" class="term-link">
                            PMID:39160155
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structural insight into 6-OH-FAD-dependent activation of hFSP1 for ferroptosis suppression.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/40233740" target="_blank" class="term-link">
                            PMID:40233740
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38514855" target="_blank" class="term-link">
                            PMID:38514855
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">RNF126 acts as an anti-ferroptotic gene by interacting with FSP1 and ubiquitinating FSP1 at the 4KR-2 sites</div>
                        
                        <div class="finding-text">"RNF126 acts as an anti-ferroptotic gene by interacting with ferroptosis suppressor protein 1 (FSP1, also known as AIFM2) and ubiquitinating FSP1 at the 4KR-2 sites"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">RNF126 deletion reduces plasma membrane localization of FSP1 and increases the CoQ/CoQH2 ratio</div>
                        
                        <div class="finding-text">"the deletion of RNF126 reduces the subcellular localization of FSP1 in the plasma membrane, resulting in an increase in the CoQ/CoQH2 ratio"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">The RNF126-FSP1-CoQ10 pathway suppresses phospholipid peroxidation and ferroptosis in vivo and in vitro</div>
                        
                        <div class="finding-text">"The RNF126-FSP1-CoQ10 pathway plays a pivotal role in suppressing phospholipid peroxidation and ferroptosis both in vivo and in vitro"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/39313331" target="_blank" class="term-link">
                            PMID:39313331
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Temsirolimus sensitizes liver cancer cells to ferroptosis by directly binding to and inhibiting FSP1 enzyme activity</div>
                        
                        <div class="finding-text">"temsirolimus sensitized liver cancer cells to ferroptosis by directly binding to and inhibiting ferroptosis suppressor protein 1 (FSP1) enzyme"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Temsirolimus-induced ferroptosis is primarily attributed to FSP1 inhibition rather than mTOR activity</div>
                        
                        <div class="finding-text">"while temsirolimus is recognized as a potent mammalian target of rapamycin (mTOR) inhibitor, its ferroptosis-inducing effect is primarily attributed to the inhibition of FSP1 rather than mTOR activity"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">The combination of temsirolimus and RSL3 suppresses liver tumor progression and is associated with increased lipid peroxidation and ferroptosis</div>
                        
                        <div class="finding-text">"the combination of temsirolimus and RSL3 effectively suppressed liver tumor progression. This tumoricidal effect was associated with increased lipid peroxidation and induction of ferroptosis"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6791306
                        
                    </span>
                </div>
                
                <div class="reference-title">TP53 stimulates AIFM2 gene expression</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AIFM2/AIFM2-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on AIFM2/FSP1 function</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AIFM2/AIFM2-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Comprehensive deep research on AIFM2/FSP1 including structural insights, regulatory mechanisms, and therapeutic implications</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 forms a functional homodimer with a unique 25-degree rotation of the FAD isoalloxazine ring; the C-terminal domain mediates dimerization essential for catalytic activity</div>
                        
                        <div class="finding-text">"The carboxy-terminal domain mediates functional dimerization of FSP1, forming a homodimer that is required for the assembly of FAD- and ubiquinone-binding pockets and for catalytic activity [lv-2023-structural-insights-abstract]. A unique feature of FSP1 structure is the ~25-degree rotation of the FAD isoalloxazine ring compared to all other known FAD-dependent oxidoreductases [lv-2023-structural-insights-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 generates 6-hydroxy-FAD which is both an active cofactor and an anti-ferroptotic compound</div>
                        
                        <div class="finding-text">"This 6-hydroxy-FAD was identified as both an active cofactor of FSP1 and a potent anti-ferroptotic compound in its own right, adding another layer to FSP1&#39;s ferroptosis-suppressing mechanisms [lv-2023-structural-insights-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 promotes ESCRT-III-dependent membrane repair by recruiting CHMP5 and CHMP6, independent of its enzymatic activity</div>
                        
                        <div class="finding-text">"FSP1 has been shown to potentiate the recruitment of ESCRT-III subunits CHMP5 and CHMP6 to the plasma membrane following ferroptosis-inducing stress. This pathway operates independently of CoQ10, suggesting that FSP1 has functions beyond its enzymatic activity."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 expression is regulated by the KEAP1-NRF2 pathway; two AREs in the FSP1 promoter bind NRF2</div>
                        
                        <div class="finding-text">"FSP1 expression is regulated at the transcriptional level by several pathways, most notably the KEAP1-NRF2 antioxidant response pathway. Two antioxidant response elements (AREs), which are canonical NRF2 binding motifs, have been identified in the FSP1 promoter region, and ChIP-qPCR assays confirmed increased NRF2 binding to these AREs upon KEAP1 knockout."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KEAP1 mutations in NSCLC lead to elevated FSP1 expression and ferroptosis/radiation resistance</div>
                        
                        <div class="finding-text">"Consequently, KEAP1 mutations, which are common in non-small cell lung cancer (NSCLC), lead to constitutive NRF2 activation and elevated FSP1 expression, contributing to ferroptosis and radiation resistance [koppula-2022-coq-fsp1-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">icFSP1 (3-phenylquinazolinone) induces FSP1 phase separation and condensate formation, displacing it from membranes</div>
                        
                        <div class="finding-text">"icFSP1 promotes FSP1 phase separation and condensate formation, displacing FSP1 from membranes and thereby preventing its anti-ferroptotic function [nakamura-2023-phase-separation-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 also localizes to lipid droplet periphery where it prevents neutral lipid peroxidation</div>
                        
                        <div class="finding-text">"Beyond the plasma membrane, FSP1 also localizes to the periphery of lipid droplets (LDs) [nakamura-2023-phase-separation-abstract]. Recent work has revealed that LD-localized FSP1 plays a critical role in preventing neutral lipid peroxidation."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">iFSP1 is human-specific; F360 is essential for binding (differs from murine FSP1)</div>
                        
                        <div class="finding-text">"Notably, iFSP1 is human-specific and does not effectively inhibit murine FSP1 due to species differences in an aromatic pocket, with F360 of human FSP1 being essential for iFSP1 binding [dasilva-2023-ifsp1-inhibition-abstract]."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37380771" target="_blank" class="term-link">
                            PMID:37380771
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Phase separation of FSP1 promotes ferroptosis</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">icFSP1 promotes FSP1 phase separation and condensate formation, displacing FSP1 from membranes</div>
                        
                        <div class="finding-text">"We show that icFSP1, unlike iFSP1, the first described on-target FSP1 inhibitor5, does not competitively inhibit FSP1 enzyme activity, but instead triggers subcellular relocalization of FSP1 from the membrane and FSP1 condensation before ferroptosis induction, in synergism with GPX4 inhibition"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">This mechanism requires N-terminal myristoylation and intrinsically disordered regions</div>
                        
                        <div class="finding-text">"N-terminal myristoylation, distinct amino acid residues and intrinsically disordered, low-complexity regions in FSP1 were identified to be essential for FSP1-dependent phase separation in cells and in vitro"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">icFSP1 impairs tumor growth in vivo and induces FSP1 condensates within tumors</div>
                        
                        <div class="finding-text">"icFSP1 impairs tumour growth and induces FSP1 condensates in tumours in vivo"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37739943" target="_blank" class="term-link">
                            PMID:37739943
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structural insights into FSP1 catalysis and ferroptosis inhibition</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Crystal structures of Gallus gallus FSP1 at 2.0A (substrate-free) and 2.6A (ubiquinone-bound)</div>
                        
                        <div class="finding-text">"We report the crystal structures of cFSP1 (residues 12‚Äì373, hereafter named cFSP1ŒîN) in its substrate-free and ubiquinone (CoQ1)-bound forms at 2.0 and 2.6‚Äâ√Ö resolution"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 contains FAD-binding domain, NAD(P)H-binding domain, and C-terminal dimerization domain</div>
                        
                        <div class="finding-text">"The structures reveal a FAD-binding domain and a NAD(P)H-binding domain, both of which are shared with AIF and NADH oxidoreductases4-9, and a characteristic carboxy-terminal domain as well"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Unique 25-degree rotation of FAD isoalloxazine ring compared to other FAD-dependent oxidoreductases</div>
                        
                        <div class="finding-text">"the isoalloxazine ring of the FAD in cFSP1 rotates ~ 25 degrees compared with that in all known structures of other FAD-dependent oxidoreductases"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">6-hydroxy-FAD identified as both active cofactor and anti-ferroptotic compound</div>
                        
                        <div class="finding-text">"identify that FSP1 can catalyze the production of H2O2 and the conversion of FAD to 6-hydroxy-FAD in the presence of oxygen and NAD(P)H in vitro, and 6-hydroxy-FAD directly inhibits ferroptosis in cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35459868" target="_blank" class="term-link">
                            PMID:35459868
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">FSP1 expression is elevated in KEAP1-mutant lung cancers</div>
                        
                        <div class="finding-text">"KEAP1 mutation or deficiency in lung cancer cells upregulates FSP1 expression through NRF2"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CoQ-FSP1 axis contributes to ferroptosis and radiation resistance</div>
                        
                        <div class="finding-text">"the ubiquinone (CoQ)-FSP1 axis mediates ferroptosis- and radiation- resistance in KEAP1 deficient lung cancer cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KEAP1 mutations lead to NRF2 activation and FSP1 upregulation</div>
                        
                        <div class="finding-text">"In this study, we identify ferroptosis suppressor protein 1 (FSP1, also known as AIFM2) as a transcriptional target of nuclear factor erythroid 2-related factor 2 (NRF2) and reveal that the ubiquinone (CoQ)-FSP1 axis mediates ferroptosis- and radiation- resistance in KEAP1 deficient lung cancer cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36264074" target="_blank" class="term-link">
                            PMID:36264074
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Two antioxidant response elements (AREs) identified in FSP1 promoter</div>
                        
                        <div class="finding-text">"two antioxidant response elements (AREs) which are well-established NRF2 binding motif were found in FSP1 gene promoter regions"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">NRF2 directly binds FSP1 promoter confirmed by ChIP-qPCR</div>
                        
                        <div class="finding-text">"ChIP-qPCR assay was performed to verify the increased binding of NRF2 to the AREs of FSP1 upon KEAP1 knockout"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">NRF2 activation upregulates FSP1 expression</div>
                        
                        <div class="finding-text">"suggesting the indispensable role of NRF2 in the regulation of FSP1 expression and ferroptosis sensitivity"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37080964" target="_blank" class="term-link">
                            PMID:37080964
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">iFSP1 shows species-specific inhibition on the human isoform</div>
                        
                        <div class="finding-text">"explore the species-specific inhibition of iFSP1 on the human isoform to gain insights into its mechanism of action"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Species-specific aromatic architecture is essential for target engagement</div>
                        
                        <div class="finding-text">"establish a critical contribution of a species-specific aromatic architecture that is essential for target engagement"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Caution is warranted when using iFSP1 in murine models</div>
                        
                        <div class="finding-text">"pose a cautionary notice for using iFSP1 in animal models, specifically murine models"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the physiological relevance of FSP1&#39;s DNA binding activity, and is it relevant to the original pro-apoptotic observations?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="Q: What is the physiological relevance of FSP1&#39;s DNA ..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What determines FSP1&#39;s distribution between plasma membrane and lipid droplets, and what are the regulatory mechanisms for partitioning?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="Q: What determines FSP1&#39;s distribution between plasma..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does FSP1 have substrate specificity for different quinone species, and what are the relative affinities and physiological relevance of each substrate?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="Q: Does FSP1 have substrate specificity for different..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Membrane fractionation with FSP1 activity assays to determine the relative contribution of plasma membrane vs lipid droplet pools to overall FSP1 function.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Plasma membrane-localized FSP1 provides the majority of ferroptosis protection under normal conditions, while lipid droplet-localized FSP1 may be more important under lipotoxic stress.</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="EXPERIMENT: Membrane fractionation with FSP1 activity assays t..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Kinetic comparison of FSP1 activity toward CoQ vs vitamin K substrates under different conditions to establish physiological substrate preferences.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: FSP1 preferentially reduces CoQ under normal conditions but may switch to vitamin K reduction when CoQ is limiting or under specific stress conditions.</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9BRQ8" data-a="EXPERIMENT: Kinetic comparison of FSP1 activity toward CoQ vs ..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Tags</h2>
        <div class="aliases">
            
            <span class="badge">ferroptosis</span>
            
        </div>
    </div>
    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AIFM2-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9BRQ8" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-15T14:31:18.134639'<br />
end_time: '2026-01-15T14:49:12.326350'<br />
duration_seconds: 1074.19<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AIFM2<br />
  gene_symbol: AIFM2<br />
  uniprot_accession: Q9BRQ8<br />
  protein_description: 'RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899,<br />
    ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900};<br />
    EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516};<br />
    AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer<br />
    of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907};<br />
    AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};'<br />
  gene_info: Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411};<br />
    Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the FAD-dependent oxidoreductase family.<br />
  protein_domains: FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2<br />
    (PF07992)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 17</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9BRQ8</li>
<li><strong>Protein Description:</strong> RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516}; AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907}; AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};</li>
<li><strong>Gene Information:</strong> Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411}; Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the FAD-dependent oxidoreductase family.</li>
<li><strong>Key Domains:</strong> FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2 (PF07992)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AIFM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AIFM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AIFM2</strong> (gene ID: AIFM2, UniProt: Q9BRQ8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="aifm2fsp1-a-comprehensive-review-of-ferroptosis-suppressor-protein-1">AIFM2/FSP1: A Comprehensive Review of Ferroptosis Suppressor Protein 1</h1>
<h2 id="1-introduction-and-summary">1. Introduction and Summary</h2>
<p>Apoptosis-inducing factor mitochondria-associated 2 (AIFM2), now more commonly known as Ferroptosis Suppressor Protein 1 (FSP1), is a flavoprotein oxidoreductase encoded by the AIFM2 gene (chromosome 10q22.1) in humans [ohiro-2002-prg3-abstract]. The protein belongs to the FAD-dependent oxidoreductase family and contains 373 amino acids with a molecular mass of approximately 40.5 kDa [ohiro-2002-prg3-abstract]. This protein has undergone a remarkable reconceptualization since its original discovery: initially characterized as a pro-apoptotic factor homologous to AIF, it is now understood to function primarily as a potent suppressor of ferroptosis, a form of iron-dependent regulated cell death driven by lipid peroxidation [doll-2019-fsp1-glutathione-abstract][bersuker-2019-coq-oxidoreductase-abstract].</p>
<p>The primary enzymatic function of FSP1 is to catalyze the NAD(P)H-dependent reduction of ubiquinone (coenzyme Q10, CoQ10) to ubiquinol (CoQ10H2), a lipophilic radical-trapping antioxidant that halts the propagation of lipid peroxides [bersuker-2019-coq-oxidoreductase-abstract][doll-2019-fsp1-glutathione-abstract]. Additionally, FSP1 reduces vitamin K to its hydroquinone form, providing another mechanism of ferroptosis suppression through a non-canonical vitamin K cycle [mishima-2022-vitamin-k-abstract]. The protein localizes primarily to the plasma membrane through N-terminal myristoylation, where it protects membrane lipids from peroxidation [bersuker-2019-coq-oxidoreductase-abstract]. The discovery of FSP1 as a parallel ferroptosis-suppressing system, independent of the canonical glutathione peroxidase 4 (GPX4) pathway, fundamentally changed the understanding of ferroptosis regulation and opened new therapeutic avenues for cancer treatment.</p>
<h2 id="2-discovery-and-nomenclature-history">2. Discovery and Nomenclature History</h2>
<p>The protein now known as FSP1 was independently discovered by multiple research groups under different names, reflecting its apparent involvement in various cellular processes. In 2002, Wu and colleagues at Peking University identified a novel AIF-homologous protein they named AMID (AIF-homologous Mitochondrion-associated Inducer of Death) [wu-2002-amid-abstract]. Their work demonstrated that AMID co-localized with mitochondria and, when overexpressed, induced caspase-independent and p53-independent apoptosis that was not inhibited by Bcl-2 [wu-2002-amid-abstract]. Concurrently, Ohiro et al. identified the same gene as PRG3 (p53-Responsive Gene 3), noting that it was induced specifically under p53-dependent apoptotic conditions in human colon cancer cells [ohiro-2002-prg3-abstract]. Interestingly, these early studies reported that an N-terminal deletion mutant lacking the putative oxidoreductase domain retained apoptotic activity, suggesting the enzymatic function was dispensable for the apoptotic pathway [ohiro-2002-prg3-abstract].</p>
<p>The paradigm shifted dramatically in October 2019 when two landmark papers published simultaneously in Nature revealed the protein's primary physiological function. Using a synthetic lethal CRISPR-Cas9 screen, Bersuker et al. at UC Berkeley identified AIFM2 as a potent ferroptosis resistance factor and renamed it Ferroptosis Suppressor Protein 1 (FSP1) [bersuker-2019-coq-oxidoreductase-abstract]. In parallel, Doll et al. from the Conrad laboratory at the Helmholtz Institute used an expression cloning approach to identify genes that could complement GPX4 loss and independently arrived at the same conclusion [doll-2019-fsp1-glutathione-abstract]. These studies established that FSP1's primary cellular function is to suppress lipid peroxidation and ferroptosis, rather than to promote apoptosis as originally proposed [doll-2019-fsp1-glutathione-abstract][bersuker-2019-coq-oxidoreductase-abstract].</p>
<h2 id="3-enzymatic-function-and-catalytic-mechanism">3. Enzymatic Function and Catalytic Mechanism</h2>
<p>FSP1 functions as a NAD(P)H-dependent quinone oxidoreductase, catalyzing the two-electron reduction of ubiquinone (CoQ10) to ubiquinol (CoQ10H2) [doll-2019-fsp1-glutathione-abstract][bersuker-2019-coq-oxidoreductase-abstract]. The reduced ubiquinol acts as a lipophilic radical-trapping antioxidant (RTA) that neutralizes lipid peroxyl radicals, thereby preventing the propagation of lipid peroxidation that would otherwise lead to ferroptosis [bersuker-2019-coq-oxidoreductase-abstract]. This reaction can be summarized as:</p>
<p><strong>CoQ10 (oxidized) + NAD(P)H + H+ ‚Üí CoQ10H2 (reduced) + NAD(P)+</strong></p>
<p>Structural insights into FSP1 catalysis came from crystal structures of Gallus gallus FSP1 solved at 2.0 √Ö (substrate-free) and 2.6 √Ö (ubiquinone-bound) resolution [lv-2023-structural-insights-abstract]. The structure reveals three distinct domains: a FAD-binding domain, a NAD(P)H-binding domain (both shared with AIF and NADH oxidoreductases), and a characteristic carboxy-terminal domain [lv-2023-structural-insights-abstract]. The carboxy-terminal domain mediates functional dimerization of FSP1, forming a homodimer that is required for the assembly of FAD- and ubiquinone-binding pockets and for catalytic activity [lv-2023-structural-insights-abstract].</p>
<p>A unique feature of FSP1 structure is the ~25-degree rotation of the FAD isoalloxazine ring compared to all other known FAD-dependent oxidoreductases [lv-2023-structural-insights-abstract]. The homodimer creates two active sites located on opposite sides of the FAD cofactor: one responsible for ubiquinone reduction and another for a unique FAD hydroxylation reaction that generates 6-hydroxy-FAD [lv-2023-structural-insights-abstract]. This 6-hydroxy-FAD was identified as both an active cofactor of FSP1 and a potent anti-ferroptotic compound in its own right, adding another layer to FSP1's ferroptosis-suppressing mechanisms [lv-2023-structural-insights-abstract].</p>
<p>Beyond ubiquinone, FSP1 also efficiently reduces vitamin K (both menaquinone and phylloquinone) to their hydroquinone forms [mishima-2022-vitamin-k-abstract]. This vitamin K reductase activity is particularly significant because it explains the warfarin-resistant vitamin K reduction pathway: FSP1 mediates vitamin K reduction independently of the canonical VKORC1-mediated pathway that is inhibited by warfarin [mishima-2022-vitamin-k-abstract]. The reduced vitamin K hydroquinone (VKH2) functions as another potent radical-trapping antioxidant that prevents lipid peroxidation, representing a third anti-ferroptotic mechanism mediated by FSP1 [mishima-2022-vitamin-k-abstract]. FSP1 can also reduce vitamin E (Œ±-tocopherol), either directly or indirectly through ubiquinol-mediated regeneration, further expanding its antioxidant capacity [mishima-2022-vitamin-k-abstract].</p>
<h3 id="substrate-specificity-and-kinetic-properties">Substrate Specificity and Kinetic Properties</h3>
<p>FSP1 demonstrates broad substrate specificity within the quinone class of molecules. The known substrates include NADH and NADPH as electron donors, and CoQ10 (ubiquinone), CoQ1 (a short-chain ubiquinone analog), menadione (vitamin K3), and resazurin as electron acceptors [nakamura-2023-integrated-screens-abstract]. Kinetic analyses have been performed using resazurin reduction as a proxy for enzymatic activity, with reactions typically containing 100 nM recombinant human FSP1 protein [dasilva-2023-ifsp1-inhibition-abstract]. Lineweaver-Burk and Dixon plot analyses revealed that FSP1 inhibitors such as iFSP1 and viFSP1 are non-competitive inhibitors, meaning they can bind the enzyme regardless of substrate presence [nakamura-2023-integrated-screens-abstract].</p>
<p>Integrated chemical and genetic screens have provided detailed insights into FSP1's catalytic mechanism [nakamura-2023-integrated-screens-abstract]. Random mutagenesis studies identified conserved binding sites for the FAD and NAD(P)H cofactors and characterized critical proton-transfer mechanisms essential for catalysis. The development of two distinct classes of FSP1 inhibitors‚ÄîiFSP1 targeting the quinone-binding pocket and viFSP1 targeting the NAD(P)H-binding pocket‚Äîconfirmed the presence of two separate functional sites [nakamura-2023-integrated-screens-abstract]. Notably, iFSP1 is human-specific and does not effectively inhibit murine FSP1 due to species differences in an aromatic pocket, with F360 of human FSP1 being essential for iFSP1 binding [dasilva-2023-ifsp1-inhibition-abstract]. This species specificity has important implications for preclinical studies in mouse models.</p>
<h2 id="4-subcellular-localization-and-membrane-association">4. Subcellular Localization and Membrane Association</h2>
<p>The subcellular localization of FSP1 is critical for its anti-ferroptotic function. The protein contains a canonical N-terminal myristoylation motif, and this post-translational modification is essential for targeting FSP1 to cellular membranes [bersuker-2019-coq-oxidoreductase-abstract]. N-myristoylation involves the attachment of myristate, a 14-carbon saturated fatty acid, to the N-terminal glycine residue by N-myristoyltransferase (NMT), mediating dynamic protein-membrane interactions [bersuker-2019-coq-oxidoreductase-abstract].</p>
<p>Myristoylated FSP1 is primarily recruited to the plasma membrane, where it functions to reduce ubiquinone to ubiquinol at the site where lipid peroxidation most threatens cellular integrity [bersuker-2019-coq-oxidoreductase-abstract]. This membrane localization is absolutely required for ferroptosis suppression: the G2A mutant, which cannot be myristoylated, shows strongly affected localization and completely loses its ferroptosis-suppressive function [bersuker-2019-coq-oxidoreductase-abstract]. Importantly, fusion of a membrane-targeting sequence (Lyn11) to the G2A mutant restores its ability to suppress ferroptosis, confirming that membrane localization, rather than myristoylation per se, is the critical requirement [bersuker-2019-coq-oxidoreductase-abstract].</p>
<p>Beyond the plasma membrane, FSP1 also localizes to the periphery of lipid droplets (LDs) [nakamura-2023-phase-separation-abstract]. Recent work has revealed that LD-localized FSP1 plays a critical role in preventing neutral lipid peroxidation, a previously unrecognized function. By recycling CoQ10 to its antioxidant form at LDs, FSP1 prevents the accumulation of oxidized triacylglycerols and cholesteryl esters, thereby maintaining lipid droplet integrity and preventing LD-initiated ferroptosis when cells are loaded with polyunsaturated fatty acid-rich lipids.</p>
<p>The early characterization of AMID/AIFM2 suggested mitochondrial localization [wu-2002-amid-abstract], and indeed the protein can associate with the outer mitochondrial membrane despite lacking a canonical mitochondrial localization sequence [wu-2002-amid-abstract]. However, the predominant and functionally relevant localization for ferroptosis suppression is the plasma membrane. Interestingly, inhibition of myristoylation with compounds like IMP-366 not only abolishes the anti-ferroptosis function of FSP1 but also promotes its nuclear translocation via importin Œ±2, suggesting complex regulation of FSP1 localization.</p>
<h2 id="5-role-in-ferroptosis-suppression-three-parallel-mechanisms">5. Role in Ferroptosis Suppression: Three Parallel Mechanisms</h2>
<p>Three distinct mechanisms by which FSP1 suppresses ferroptosis have been elucidated, representing a comprehensive defense system against lipid peroxidation.</p>
<h3 id="the-fsp1-coq10-nadph-pathway">The FSP1-CoQ10-NAD(P)H Pathway</h3>
<p>The primary and best-characterized mechanism involves FSP1's oxidoreductase activity at the plasma membrane [doll-2019-fsp1-glutathione-abstract][bersuker-2019-coq-oxidoreductase-abstract]. FSP1 catalyzes the reduction of ubiquinone (CoQ10) to ubiquinol (CoQ10H2) using NAD(P)H as the electron donor. The resulting ubiquinol functions as a lipophilic radical-trapping antioxidant that directly scavenges lipid peroxyl radicals, breaking the chain reaction of lipid peroxidation [doll-2019-fsp1-glutathione-abstract]. This pathway operates entirely independently of the canonical GPX4/glutathione system, providing cells with a parallel defense mechanism. The physiological importance of this redundancy is evident in the observation that cancer cells with high FSP1 expression are resistant to GPX4 inhibitors [bersuker-2019-coq-oxidoreductase-abstract].</p>
<h3 id="the-fsp1-vitamin-k-nadph-pathway">The FSP1-Vitamin K-NAD(P)H Pathway</h3>
<p>The second mechanism involves FSP1's vitamin K reductase activity [mishima-2022-vitamin-k-abstract]. FSP1 efficiently reduces vitamin K (menaquinone and phylloquinone) to their corresponding hydroquinones using NAD(P)H. These vitamin K hydroquinones function as potent radical-trapping antioxidants, similar to ubiquinol, preventing lipid peroxidation [mishima-2022-vitamin-k-abstract]. This pathway is warfarin-resistant, as it operates independently of the VKORC1 enzyme that is the target of warfarin [mishima-2022-vitamin-k-abstract]. The FSP1-vitamin K pathway represents a non-canonical vitamin K cycle with clear anti-ferroptotic function beyond vitamin K's classical role in blood coagulation [mishima-2022-vitamin-k-abstract].</p>
<h3 id="the-fsp1-escrt-iii-membrane-repair-pathway">The FSP1-ESCRT-III Membrane Repair Pathway</h3>
<p>A third mechanism involves FSP1's role in promoting ESCRT-III-dependent membrane repair. The ESCRT-III (Endosomal Sorting Complexes Required for Transport-III) machinery mediates membrane deformation and fission, and plays a role in repairing damaged plasma membranes. FSP1 has been shown to potentiate the recruitment of ESCRT-III subunits CHMP5 and CHMP6 to the plasma membrane following ferroptosis-inducing stress. Knockdown of FSP1 suppresses the membrane accumulation of these ESCRT-III components, while overexpression of CHMP5 can rescue cells from ferroptosis even when FSP1 is silenced. This pathway operates independently of CoQ10, suggesting that FSP1 has functions beyond its enzymatic activity.</p>
<h2 id="6-relationship-to-gpx4-and-the-ferroptosis-defense-network">6. Relationship to GPX4 and the Ferroptosis Defense Network</h2>
<p>Prior to the discovery of FSP1's anti-ferroptotic function, GPX4 (glutathione peroxidase 4) was considered the sole master regulator of ferroptosis. GPX4 reduces lipid hydroperoxides to lipid alcohols using glutathione (GSH) as a cofactor, representing the canonical ferroptosis defense system [doll-2019-fsp1-glutathione-abstract]. The identification of FSP1 revealed that cells possess parallel, independent mechanisms to prevent ferroptosis.</p>
<p>The FSP1-CoQ10-NAD(P)H pathway operates as a stand-alone parallel system that cooperates with the GPX4-glutathione axis [doll-2019-fsp1-glutathione-abstract]. These two systems provide complementary protection: GPX4 directly reduces lipid hydroperoxides that have already formed, while FSP1 generates ubiquinol that scavenges lipid peroxyl radicals before they can propagate [doll-2019-fsp1-glutathione-abstract][bersuker-2019-coq-oxidoreductase-abstract]. The existence of this backup system explains why some cancer cells survive GPX4 inhibition‚Äîthey upregulate or rely on FSP1-mediated protection [bersuker-2019-coq-oxidoreductase-abstract].</p>
<p>A third component of the ferroptosis defense network is dihydroorotate dehydrogenase (DHODH), a flavin-dependent mitochondrial enzyme that, in addition to its canonical role in pyrimidine biosynthesis, regenerates ubiquinol in the inner mitochondrial membrane. While FSP1 protects the plasma membrane and other extramitochondrial membranes, DHODH specifically protects the mitochondrial compartment. GPX4 provides protection across multiple compartments including the cytoplasm and mitochondrial matrix. This compartmentalization allows cells to mount context-specific responses depending on the source of oxidative stress.</p>
<h2 id="7-regulation-of-fsp1-expression">7. Regulation of FSP1 Expression</h2>
<p>FSP1 expression is regulated at the transcriptional level by several pathways, most notably the KEAP1-NRF2 antioxidant response pathway. Nuclear factor erythroid 2-related factor 2 (NRF2) is a master transcription factor that controls the expression of numerous antioxidant and cytoprotective genes. Under normal conditions, NRF2 is targeted for degradation by KEAP1 (Kelch-like ECH-associated protein 1); however, under oxidative stress or when KEAP1 is mutated (as frequently occurs in lung cancers), NRF2 accumulates and activates its target genes [koppula-2022-coq-fsp1-abstract][emmanuel-2022-nrf2-target-abstract].</p>
<p>Analysis of NRF2 ChIP-seq data revealed strong association between NRF2 and the FSP1 gene promoter [emmanuel-2022-nrf2-target-abstract]. Two antioxidant response elements (AREs), which are canonical NRF2 binding motifs, have been identified in the FSP1 promoter region, and ChIP-qPCR assays confirmed increased NRF2 binding to these AREs upon KEAP1 knockout [emmanuel-2022-nrf2-target-abstract]. Consequently, KEAP1 mutations, which are common in non-small cell lung cancer (NSCLC), lead to constitutive NRF2 activation and elevated FSP1 expression, contributing to ferroptosis and radiation resistance [koppula-2022-coq-fsp1-abstract].</p>
<p>The original identification of PRG3 (AIFM2) as a p53-responsive gene indicates that p53 can also regulate FSP1 expression [ohiro-2002-prg3-abstract]. A p53-responsive element was identified in the PRG3 gene, and expression was induced by activation of endogenous p53 [ohiro-2002-prg3-abstract]. This adds complexity to FSP1 regulation in cancer contexts where p53 is frequently mutated.</p>
<p>Myristoylation of FSP1 is also subject to regulation. N-myristoyltransferase 2 (NMT2) is the enzyme responsible for FSP1 myristoylation, and NADPH has been shown to interact with NMT2 and upregulate N-myristoylated FSP1 levels. This creates a connection between cellular NADPH levels and FSP1 membrane localization, linking metabolic state to ferroptosis sensitivity.</p>
<h2 id="8-therapeutic-implications-and-cancer-relevance">8. Therapeutic Implications and Cancer Relevance</h2>
<p>The discovery that FSP1 mediates ferroptosis resistance has profound implications for cancer therapy. FSP1 expression levels correlate with ferroptosis resistance across hundreds of cancer cell lines, and the protein is highly expressed in various tumors [bersuker-2019-coq-oxidoreductase-abstract]. In lung cancer particularly, FSP1 expression is elevated in tumors with KEAP1 mutations, contributing to both chemotherapy and radiation resistance [koppula-2022-coq-fsp1-abstract].</p>
<p>The first FSP1-specific inhibitor, iFSP1, was identified through counter-screening approaches and inhibits human FSP1 with an EC50 of approximately 103 nM [bersuker-2019-coq-oxidoreductase-abstract]. In preclinical models, iFSP1 effectively induced ferroptosis in hepatocellular carcinoma (HCC) cells and suppressed tumor growth while also enhancing anti-tumor immune responses by increasing immune infiltration of dendritic cells, macrophages, and T cells. The combination of FSP1 inhibition with immune checkpoint inhibitors shows synergistic effects.</p>
<p>A novel class of FSP1 inhibitors, the 3-phenylquinazolinones (exemplified by icFSP1), was identified through small molecule library screening [nakamura-2023-phase-separation-abstract]. Unlike iFSP1, which competitively inhibits FSP1 enzymatic activity, icFSP1 promotes FSP1 phase separation and condensate formation, displacing FSP1 from membranes and thereby preventing its anti-ferroptotic function [nakamura-2023-phase-separation-abstract]. This mechanism requires FSP1's N-terminal myristoylation and intrinsically disordered regions. Importantly, icFSP1 impairs tumor growth in vivo and induces FSP1 condensates within tumors, representing a novel therapeutic strategy [nakamura-2023-phase-separation-abstract].</p>
<p>The combination of FSP1 inhibitors with GPX4 inhibitors shows synergistic effects in inducing ferroptosis, as cancer cells must then rely on neither defense pathway [doll-2019-fsp1-glutathione-abstract]. Similarly, combined inhibition of FSP1 and DHODH synergistically promotes ferroptosis by disabling both plasma membrane and mitochondrial CoQ10 reduction. These combination strategies are particularly relevant for cancers with KEAP1 mutations or high basal ferroptosis resistance.</p>
<p>Recent in vivo studies using genetically engineered mouse models have provided compelling evidence for FSP1's role in tumor biology. In lung adenocarcinoma models, tumor-specific loss-of-function of FSP1 resulted in increased lipid peroxidation and robust suppression of tumorigenesis, confirming that lung tumors are highly sensitive to ferroptosis. Importantly, across multiple preclinical models, FSP1 was required for ferroptosis protection in vivo but not in vitro, underscoring a heightened need to buffer lipid peroxidation under physiological conditions. High FSP1 expression is linked to worse prognosis in human lung adenocarcinoma, supporting its potential as both a therapeutic target and prognostic biomarker.</p>
<h2 id="9-fsp1-in-neurodegeneration">9. FSP1 in Neurodegeneration</h2>
<p>Beyond cancer, ferroptosis has emerged as a significant contributor to neurodegenerative diseases, and FSP1's role as a ferroptosis suppressor has implications for understanding neurological pathology. The brain presents a unique environment for ferroptosis regulation due to its high oxygen consumption, abundant polyunsaturated fatty acids, and robust iron utilization for neurotransmitter synthesis and myelin formation, making the central nervous system especially vulnerable to ferroptotic damage.</p>
<p>Ferroptosis has been associated with the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, and amyotrophic lateral sclerosis. In AD, iron dysregulation and lipid peroxidation predominate in cortical and hippocampal regions, affecting both neurons and glial cells. In PD, the substantia nigra pars compacta (SNpc), where dopaminergic neurons are concentrated, shows particular susceptibility to ferroptotic damage. Regional differences in the expression of ferroptosis regulators, including FSP1, GPX4, and system Xc‚àí, likely underlie these distinct regional vulnerabilities. Notably, diseases associated with AIFM2/FSP1 in curated databases include ovarian cancer and Parkinson's disease.</p>
<p>The regulation of FSP1 expression by NRF2 is particularly relevant in the neurological context, as NRF2 activation has emerged as a potential neuroprotective strategy. Since FSP1 is a target gene of NRF2, compounds that activate NRF2 signaling could potentially upregulate FSP1 expression and enhance protection against neuronal ferroptosis. This presents opportunities for therapeutic intervention in neurodegenerative conditions where ferroptosis contributes to disease progression.</p>
<h2 id="10-open-questions">10. Open Questions</h2>
<p>Despite significant advances in understanding FSP1 biology, several important questions remain:</p>
<p><strong>Structural and mechanistic questions:</strong> The crystal structures solved to date are from chicken FSP1, and human FSP1 structures would provide more direct insights into inhibitor design and species-specific differences in iFSP1 sensitivity. The mechanism by which FSP1 promotes ESCRT-III-dependent membrane repair independently of its enzymatic activity is not fully understood.</p>
<p><strong>Physiological roles beyond ferroptosis:</strong> The original characterization of AMID/PRG3 as a pro-apoptotic protein raises questions about context-dependent functions. Under what conditions, if any, does FSP1 contribute to cell death rather than survival? The observation that oxidoreductase-dead mutants retained apoptotic activity [ohiro-2002-prg3-abstract] suggests functions independent of enzymatic activity that merit further investigation.</p>
<p><strong>Lipid droplet function:</strong> The recent discovery of FSP1's role in protecting lipid droplets from neutral lipid peroxidation opens new avenues of investigation. How does FSP1 localization to lipid droplets versus plasma membrane affect its function, and how is this distribution regulated?</p>
<p><strong>Phase separation biology:</strong> The discovery that FSP1 can undergo phase separation when displaced from membranes raises questions about whether this represents purely a loss-of-function phenotype or whether FSP1 condensates have biological functions [nakamura-2023-phase-separation-abstract].</p>
<p><strong>Therapeutic development:</strong> The first-generation FSP1 inhibitor iFSP1 has limitations including species specificity (poor activity against mouse FSP1) and unfavorable pharmacological properties. Development of improved inhibitors suitable for clinical translation remains an active area of research. The identification of species-independent inhibitors (viFSP1) targeting the NAD(P)H-binding pocket represents progress in this direction.</p>
<p><strong>Biomarker potential:</strong> Whether FSP1 expression levels could serve as predictive biomarkers for ferroptosis-inducing therapies remains to be validated in clinical settings. The correlation between FSP1 expression and ferroptosis resistance in cell lines needs confirmation in patient tumors.</p>
<p><strong>Immune implications:</strong> Preliminary data suggest that FSP1 inhibition enhances anti-tumor immune responses, but the mechanisms linking ferroptosis to immunogenic cell death and immune activation require further investigation.</p>
<h2 id="11-references">11. References</h2>
<ol>
<li>
<p><strong>[doll-2019-fsp1-glutathione-abstract]</strong> Doll S, Freitas FP, Shah R, Aldrovandi M, et al. FSP1 is a glutathione-independent ferroptosis suppressor. <em>Nature</em>. 2019;575(7784):693-698. PMID: 31634899. DOI: 10.1038/s41586-019-1707-0</p>
</li>
<li>
<p><strong>[bersuker-2019-coq-oxidoreductase-abstract]</strong> Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ, Olzmann JA. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. <em>Nature</em>. 2019;575(7784):688-692. PMID: 31634900. PMCID: PMC6883167. DOI: 10.1038/s41586-019-1705-2</p>
</li>
<li>
<p><strong>[mishima-2022-vitamin-k-abstract]</strong> Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. <em>Nature</em>. 2022;608(7924):778-783. PMID: 35922516. DOI: 10.1038/s41586-022-05022-3</p>
</li>
<li>
<p><strong>[lv-2023-structural-insights-abstract]</strong> Lv Y, Liang C, Sun Q, Zhu J, Xu H, Li X, Li YY, Wang Q, Yuan H, Chu B, Zhu D. Structural insights into FSP1 catalysis and ferroptosis inhibition. <em>Nature Communications</em>. 2023;14:5933. PMID: 37739943. DOI: 10.1038/s41467-023-41626-7</p>
</li>
<li>
<p><strong>[wu-2002-amid-abstract]</strong> Wu M, Xu LG, Li X, Zhai Z, Shu HB. AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis. <em>Journal of Biological Chemistry</em>. 2002;277(28):25617-25623. PMID: 11980907. DOI: 10.1074/jbc.M202285200</p>
</li>
<li>
<p><strong>[ohiro-2002-prg3-abstract]</strong> Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N. A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF). <em>FEBS Letters</em>. 2002;524(1-3):163-171. PMID: 12135761. DOI: 10.1016/s0014-5793(02)03049-1</p>
</li>
<li>
<p><strong>[nakamura-2023-phase-separation-abstract]</strong> Nakamura T, Hipp C, Mour√£o ASD, Borggr√§fe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E, Lytton E, Emler D, Proneth B, Sattler M, Conrad M. Phase separation of FSP1 promotes ferroptosis. <em>Nature</em>. 2023;619(7969):371-377. PMID: 37380771. DOI: 10.1038/s41586-023-06255-6</p>
</li>
<li>
<p><strong>[koppula-2022-coq-fsp1-abstract]</strong> Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan B. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. <em>Nature Communications</em>. 2022;13(1):2206. PMID: 35459868. DOI: 10.1038/s41467-022-29905-1</p>
</li>
<li>
<p><strong>[emmanuel-2022-nrf2-target-abstract]</strong> Emmanuel N, Li H, Chen J, Zhang Y. FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers. <em>Oncotarget</em>. 2022;13:1136-1139. PMID: 36264074. DOI: 10.18632/oncotarget.28301</p>
</li>
<li>
<p><strong>[nakamura-2023-integrated-screens-abstract]</strong> Nakamura T, Mishima E, Yamada N, Mour√£o ASD, Tr√ºmbach D, Doll S, Wanninger J, Lytton E, Sennhenn P, Xavier da Silva TN, Friedmann Angeli JP, Sattler M, Proneth B, Conrad M. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation. <em>Nature Structural &amp; Molecular Biology</em>. 2023;30(11):1806-1815. PMID: 37957306. PMCID: PMC10643123. DOI: 10.1038/s41594-023-01136-y</p>
</li>
<li>
<p><strong>[dasilva-2023-ifsp1-inhibition-abstract]</strong> Xavier da Silva TN, Schulte C, Alves AN, Maric HM, Friedmann Angeli JP. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. <em>Cell Death &amp; Disease</em>. 2023;14(4):281. PMID: 37080964. DOI: 10.1038/s41419-023-05787-z</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>bersuker-2019-coq-oxidoreductase-abstract.md</li>
<li>bersuker-2019-coq-oxidoreductase-summary.md</li>
<li>dasilva-2023-ifsp1-inhibition-abstract.md</li>
<li>doll-2019-fsp1-glutathione-abstract.md</li>
<li>doll-2019-fsp1-glutathione-summary.md</li>
<li>emmanuel-2022-nrf2-target-abstract.md</li>
<li>koppula-2022-coq-fsp1-abstract.md</li>
<li>lv-2023-structural-insights-abstract.md</li>
<li>lv-2023-structural-insights-summary.md</li>
<li>mishima-2022-vitamin-k-abstract.md</li>
<li>mishima-2022-vitamin-k-summary.md</li>
<li>nakamura-2023-integrated-screens-abstract.md</li>
<li>nakamura-2023-phase-separation-abstract.md</li>
<li>nakamura-2023-phase-separation-summary.md</li>
<li>ohiro-2002-prg3-abstract.md</li>
<li>wu-2002-amid-abstract.md</li>
<li>wu-2002-amid-summary.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AIFM2-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9BRQ8" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: true<br />
start_time: '2026-01-19T15:33:54.871301'<br />
end_time: '2026-01-19T15:33:54.873380'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AIFM2<br />
  gene_symbol: AIFM2<br />
  uniprot_accession: Q9BRQ8<br />
  protein_description: 'RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899,<br />
    ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900};<br />
    EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516};<br />
    AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer<br />
    of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907};<br />
    AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};'<br />
  gene_info: Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411};<br />
    Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the FAD-dependent oxidoreductase family.<br />
  protein_domains: FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2<br />
    (PF07992)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 24</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9BRQ8</li>
<li><strong>Protein Description:</strong> RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516}; AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907}; AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};</li>
<li><strong>Gene Information:</strong> Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411}; Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the FAD-dependent oxidoreductase family.</li>
<li><strong>Key Domains:</strong> FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2 (PF07992)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AIFM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AIFM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AIFM2</strong> (gene ID: AIFM2, UniProt: Q9BRQ8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9BRQ8</li>
<li><strong>Protein Description:</strong> RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516}; AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907}; AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};</li>
<li><strong>Gene Information:</strong> Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411}; Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the FAD-dependent oxidoreductase family.</li>
<li><strong>Key Domains:</strong> FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2 (PF07992)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AIFM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AIFM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AIFM2</strong> (gene ID: AIFM2, UniProt: Q9BRQ8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan status: We verified the target gene/protein identity and synthesized recent primary and review evidence (2019‚Äì2024) on AIFM2/FSP1 (UniProt Q9BRQ8) to address function, localization, structure, regulation, pathway context, applications, expert perspectives, and quantitative findings.</p>
<p>Comprehensive research report: AIFM2/FSP1 (Human; UniProt Q9BRQ8)</p>
<p>Identity and definitions<br />
- Verification: AIFM2 (aliases AMID/PRG3) encodes a human FAD-dependent oxidoreductase renamed ferroptosis suppressor protein 1 (FSP1) for its role in suppressing ferroptosis independently of GPX4. Organism: Homo sapiens. Protein family/domains: FAD/NAD(P)H-binding oxidoreductase fold consistent with FAD/NAD-binding domains; structural studies confirm this architecture (Nature Communications, Sep 2023, https://doi.org/10.1038/s41467-023-41626-7) (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9). The discovery paper established FSP1 as a glutathione-independent ferroptosis suppressor (Nature, Oct 2019, https://doi.org/10.1038/s41586-019-1707-0) (doll2019fsp1isa pages 1-5, doll2019fsp1isa pages 5-9).</p>
<p>Key concepts and current understanding<br />
- Ferroptosis: iron-dependent cell death driven by phospholipid peroxidation of PUFA-containing membranes. Cells deploy parallel antioxidant systems: GPX4/GSH and a GPX4-independent FSP1‚ÄìCoQ system; expert reviews and guidelines position FSP1 as a principal non-GPX4 defense (Nat Rev Mol Cell Biol, Feb 2024, https://doi.org/10.1038/s41580-024-00703-5; Nat Cell Biol guideline, Feb 2024, https://doi.org/10.1038/s41556-024-01360-8) (deol2025vitaminb2metabolism pages 30-35).</p>
<p>Primary biochemical function (enzyme, substrates, products)<br />
- Reaction: NAD(P)H-dependent reduction of membrane-embedded ubiquinone (CoQ10) to ubiquinol (CoQ10H2), which acts as a radical-trapping antioxidant to terminate lipid peroxyl radicals, thereby suppressing ferroptosis (Nature, 2019) (doll2019fsp1isa pages 1-5, doll2019fsp1isa pages 5-9).<br />
- Substrate specificity: FSP1 reduces ubiquinone analogs; dehydroascorbate, oxidized glutathione, and tert-butyl hydroperoxide are not substrates in tested assays (Nature, 2019) (doll2019fsp1isa pages 5-9).<br />
- Vitamin K reduction: FSP1 can also reduce vitamin K to its hydroquinone (VKH2), establishing a non-canonical vitamin K redox cycle relevant to ferroptosis suppression; vitamin K species protect against GPX4-loss ferroptosis in cells and in vivo (summarized in 2022 review and 2023‚Äì2024 expert sources) (Molecular Biomedicine, Nov 2022, https://doi.org/10.1186/s43556-022-00105-z; Cell Metabolism, Aug 2023, https://doi.org/10.1016/j.cmet.2023.06.014; Nat Rev Mol Cell Biol, 2024) (zeng2022theantiferroptoticrole pages 1-3, deol2025vitaminb2metabolism pages 30-35).</p>
<p>Subcellular localization and determinants<br />
- N-myristoylation at the N-terminus is essential for anti-ferroptotic function and membrane targeting; mutation (G2A) or N-myristoyltransferase inhibition (IMP-1088) abolishes protection (Nature, 2019) (doll2019fsp1isa pages 1-5, doll2019fsp1isa pages 5-9, doll2019fsp1isa pages 14-18).<br />
- Localization: enriched at the plasma membrane, periphery of lipid droplets, and partially overlapping ER/Golgi; membrane association is needed for suppressing lipid peroxidation at the cell boundary (2019 primary; 2022 review) (doll2019fsp1isa pages 1-5, zeng2022theantiferroptoticrole pages 1-3).</p>
<p>Structural and mechanistic insights (2023 update)<br />
- Domain architecture: distinct FAD-binding and NAD(P)H-binding domains plus a carboxy-terminal domain (CTD) unique to FSP1 (Nature Communications, Sep 2023) (lv2023structuralinsightsinto pages 1-2).<br />
- Dimerization: CTD mediates functional homodimerization; dimer formation creates two active centers on opposite sides of FAD‚Äîone for ubiquinone reduction, the other for a unique FAD hydroxylation reaction (Nature Communications, Sep 2023) (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9).<br />
- 6‚Äëhydroxy‚ÄëFAD: In vitro, FSP1 can generate H2O2 and convert bound FAD to 6‚Äëhydroxy‚ÄëFAD under oxygen and NAD(P)H; 6‚Äëhydroxy‚ÄëFAD acts as an active cofactor that directly inhibits ferroptosis in cells (Nature Communications, Sep 2023) (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9).</p>
<p>Regulation of FSP1 abundance and activity<br />
- Myristoylation: prerequisite for membrane localization and activity (Nature, 2019) (doll2019fsp1isa pages 1-5, doll2019fsp1isa pages 5-9, doll2019fsp1isa pages 14-18).<br />
- Ubiquitination: RNF126 is an E3 ligase that ubiquitinates FSP1 at defined lysine clusters; RNF126 loss reduces FSP1 plasma-membrane localization and increases the CoQ/CoQH2 ratio, sensitizing to ferroptosis in medulloblastoma models (Oncogene, Mar 2024, https://doi.org/10.1038/s41388-024-02949-x) (xie2024rnf126mediatedubiquitinationof pages 1-4).<br />
- Cofactor/stability coupling: FSP1 is a FAD-binding oxidoreductase; FAD availability and binding promote stability, while FAD-free FSP1 is targeted for ubiquitin‚Äìproteasome degradation (bioRxiv, Aug 2025, https://doi.org/10.1101/2025.08.05.668752) (deol2025vitaminb2metabolism pages 13-17). (Note: preprint; mechanistic alignment with FAD-dependent oxidoreductase biology.)</p>
<p>Pathway context and related processes<br />
- GPX4-independent ferroptosis suppression: FSP1/CoQ10/NAD(P)H axis forms a parallel membrane antioxidant system; COQ2 loss diminishes FSP1 protection, supporting CoQ dependence (Nature, 2019) (doll2019fsp1isa pages 5-9, doll2019fsp1isa pages 1-5).<br />
- Vitamin K axis in ferroptosis: p53‚ÄìVKORC1L1 regulation links vitamin K metabolism to tumor suppression and ferroptosis responses; FSP1 provides vitamin K reduction to VKH2 as an anti-ferroptotic route (Cell Metabolism, Aug 2023, https://doi.org/10.1016/j.cmet.2023.06.014; Nat Cell Biol guideline, 2024) (deol2025vitaminb2metabolism pages 30-35).<br />
- ESCRT-III membrane repair: FSP1 promotes ESCRT-III‚Äìdependent membrane repair (CHMP5/CHMP6), constituting an additional anti-ferroptotic mechanism beyond CoQ reduction (Molecular Biomedicine, Nov 2022, https://doi.org/10.1186/s43556-022-00105-z) (zeng2022theantiferroptoticrole pages 1-3).</p>
<p>Recent developments (prioritized 2023‚Äì2024)<br />
- Structural mechanism (2023): dimerization-dependent dual active sites and 6‚Äëhydroxy‚ÄëFAD formation; mechanistic promiscuity for CoQ and vitamin K reduction, clarifying catalytic basis for ferroptosis suppression (Nature Communications, Sep 2023, https://doi.org/10.1038/s41467-023-41626-7) (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9).<br />
- Ubiquitination control (2024): RNF126 directs FSP1 ubiquitination that maintains plasma membrane localization and anti-ferroptotic CoQH2 pools in pediatric brain tumors (Oncogene, Mar 2024, https://doi.org/10.1038/s41388-024-02949-x) (xie2024rnf126mediatedubiquitinationof pages 1-4).<br />
- Vitamin K/p53 axis (2023‚Äì2024): VKORC1L1 upregulation by p53 supports vitamin K metabolism for ferroptosis control; non-canonical vitamin K cycle including FSP1 highlighted by reviews/guidelines (Cell Metabolism, Aug 2023; Nat Cell Biol, 2024) (deol2025vitaminb2metabolism pages 30-35).<br />
- Drug repurposing (2024): Temsirolimus directly inhibits FSP1 enzymatic activity to induce ferroptosis and synergizes with GPX4 inhibition in liver cancer models (J Mol Cell Biol, Sep 2024, https://doi.org/10.1093/jmcb/mjae036) (tian2024temsirolimusinhibitsfsp1 pages 2-5).<br />
- Inhibitor landscape and species selectivity (2024): First-generation inhibitor iFSP1 shows species-selective engagement; mechanistic characterization provides guidance for second-generation inhibitor design and for interpreting murine efficacy studies (da Silva et al., 2024) (silva20242.4manuscriptiva pages 104-108).</p>
<p>Current applications and real-world implementations<br />
- Oncology combinations: In vitro and in vivo data show that inhibiting FSP1 (genetically or pharmacologically) can convert GPX4-resistant contexts to ferroptosis-sensitive, including synergy of temsirolimus with RSL3 in liver cancer models (J Mol Cell Biol, 2024) (tian2024temsirolimusinhibitsfsp1 pages 2-5).<br />
- Prognostic/biomarker potential: Clinical pathology study in lung adenocarcinoma links GPX4/FSP1/4‚ÄëHNE expression patterns to prognosis; low FSP1 associates with unfavorable relapse-free survival, motivating ferroptosis-based strategies (Cancers, Nov 2024, https://doi.org/10.3390/cancers16223888) (zeng2022theantiferroptoticrole pages 3-3).<br />
- Non-ferroptosis function affecting therapy: In BRCA-proficient ovarian cancer, FSP1 inhibition (iFSP1) enhances olaparib sensitivity through a non-ferroptotic mechanism by disrupting Ku70 PARylation and DNA-PKcs recruitment at double-strand breaks; combination shows synergy in organoids and xenografts (Cell Death Differentiation, Feb 2024, https://doi.org/10.1038/s41418-024-01263-z) (xie2024rnf126mediatedubiquitinationof pages 1-4).</p>
<p>Expert opinions and authoritative guidance<br />
- Cell biology and therapeutic framing: 2024 reviews/guidelines emphasize FSP1 as a membrane oxidoreductase that regenerates CoQ and vitamin K hydroquinones to stop lipid peroxidation, operating alongside GPX4, and highlight the therapeutic promise of targeting FSP1 in cancer while considering systemic risks (Nat Rev Mol Cell Biol, Feb 2024; Nat Cell Biol guideline, Feb 2024) (deol2025vitaminb2metabolism pages 30-35).</p>
<p>Relevant quantitative/statistical data and phenotypes<br />
- Dependency and resistance correlations: Across large cancer cell panels, higher FSP1 expression correlates with resistance to ferroptosis inducers, whereas low FSP1 correlates with GPX4 dependency; FSP1 knockout sensitizes cells to RSL3; combined GPX4+FSP1 deletion slows xenograft growth, whereas GPX4 deletion alone may not, depending on context (Nature, Oct 2019) (doll2019fsp1isa pages 5-9, doll2019fsp1isa pages 1-5).<br />
- Clinical association: In lung adenocarcinoma cohorts, low FSP1 expression was associated with worse relapse-free survival, supporting biomarker development for ferroptosis-targeted strategies (Cancers, Nov 2024) (zeng2022theantiferroptoticrole pages 3-3).<br />
- Pharmacology: Temsirolimus-induced ferroptosis in GPX4-defective liver cancer cells is FSP1-dependent; combination with RSL3 robustly increases lipid peroxidation and suppresses tumor progression in xenograft models (J Mol Cell Biol, Sep 2024) (tian2024temsirolimusinhibitsfsp1 pages 2-5).</p>
<p>Notes on localization/biophysics and catalysis<br />
- Membrane proximity is integral to function; N-myristoylation positions FSP1 for reduction of membrane CoQ pools at the plasma membrane and possibly lipid droplets; inhibition or mutation of the myristoylation site abolishes protection (Nature, 2019; Molecular Biomedicine, 2022) (doll2019fsp1isa pages 1-5, zeng2022theantiferroptoticrole pages 1-3).<br />
- Structural catalysis supports two-electron transfer from NAD(P)H via FAD to quinone substrates (CoQ, vitamin K) and a coupled oxygen-reduction chemistry that can yield 6‚Äëhydroxy‚ÄëFAD, proposed to contribute to ferroptosis suppression (Nature Communications, 2023) (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9).</p>
<p>Therapeutic targeting and tool compounds<br />
- iFSP1/icFSP1: First-generation FSP1 inhibitors (e.g., iFSP1) sensitize to ferroptosis but show species-selective target engagement; use with caution in murine systems and prioritize human-targeted development (2024 mechanistic characterization) (silva20242.4manuscriptiva pages 104-108).<br />
- Temsirolimus: FDA-approved mTOR inhibitor repurposed as a direct FSP1 enzyme inhibitor; demonstrates synergy with GPX4 inhibition and anti-tumor efficacy in liver cancer models (J Mol Cell Biol, 2024, https://doi.org/10.1093/jmcb/mjae036) (tian2024temsirolimusinhibitsfsp1 pages 2-5).<br />
- Strategic combinations: Reviews/guidelines recommend dual targeting of GPX4 and FSP1 systems to overcome redundancy in ferroptosis defenses, with attention to tissue risks (Nat Rev Mol Cell Biol, 2024; Nat Cell Biol guideline, 2024) (deol2025vitaminb2metabolism pages 30-35).</p>
<p>Compliance with identification safeguards<br />
- Symbol/organism verification: All cited mechanistic and structural work refers to human AIFM2/FSP1 or closely homologous orthologs; structural findings from Gallus gallus FSP1 are applied mechanistically to human AIFM2 given high conservation and validation in human cells (Nature Communications, 2023) (lv2023structuralinsightsinto pages 1-2). The protein family and domain assignments (FAD/NAD-binding oxidoreductase) align with UniProt descriptors provided by the user (lv2023structuralinsightsinto pages 1-2, doll2019fsp1isa pages 1-5).</p>
<p>Cited sources (URLs and publication dates)<br />
- Doll et al., Nature, Oct 2019. FSP1 as a GPX4-independent ferroptosis suppressor; N-myristoylation, CoQ reduction. https://doi.org/10.1038/s41586-019-1707-0 (doll2019fsp1isa pages 1-5, doll2019fsp1isa pages 5-9).<br />
- Lv et al., Nature Communications, Sep 2023. FSP1 structural mechanism; CTD-mediated dimerization; 6-hydroxy-FAD. https://doi.org/10.1038/s41467-023-41626-7 (lv2023structuralinsightsinto pages 1-2, lv2023structuralinsightsinto pages 8-9).<br />
- Zeng et al., Molecular Biomedicine, Nov 2022. Review summarizing FSP1 mechanisms, vitamin K reduction, ESCRT-III. https://doi.org/10.1186/s43556-022-00105-z (zeng2022theantiferroptoticrole pages 1-3).<br />
- Yang et al., Cell Metabolism, Aug 2023. p53‚ÄìVKORC1L1 regulation; vitamin K metabolism and ferroptosis. https://doi.org/10.1016/j.cmet.2023.06.014 (deol2025vitaminb2metabolism pages 30-35).<br />
- Dixon &amp; Olzmann, Nat Rev Mol Cell Biol, Feb 2024. Cell biology of ferroptosis; FSP1 roles in CoQ and vitamin K cycling. https://doi.org/10.1038/s41580-024-00703-5 (deol2025vitaminb2metabolism pages 30-35).<br />
- Dai et al., Nature Cell Biology guideline, Feb 2024. Molecular ecosystem regulating ferroptosis; FSP1 membrane repair/vitamin K. https://doi.org/10.1038/s41556-024-01360-8 (deol2025vitaminb2metabolism pages 30-35).<br />
- Xie et al., Oncogene, Mar 2024. RNF126-mediated ubiquitination controls FSP1 membrane localization and ferroptosis resistance in G3 medulloblastoma. https://doi.org/10.1038/s41388-024-02949-x (xie2024rnf126mediatedubiquitinationof pages 1-4).<br />
- Miao et al., Cell Death &amp; Differentiation, Feb 2024. FSP1 inhibition enhances olaparib sensitivity via non-ferroptosis (Ku70/PARylation) mechanism. https://doi.org/10.1038/s41418-024-01263-z (xie2024rnf126mediatedubiquitinationof pages 1-4).<br />
- Tian et al., J Mol Cell Biol, Sep 2024. Temsirolimus directly inhibits FSP1 to induce ferroptosis; synergy with GPX4 inhibitor RSL3; liver cancer models. https://doi.org/10.1093/jmcb/mjae036 (tian2024temsirolimusinhibitsfsp1 pages 2-5).<br />
- Takahara et al., Cancers, Nov 2024. Clinical correlations of GPX4/FSP1/4‚ÄëHNE in lung adenocarcinoma. https://doi.org/10.3390/cancers16223888 (zeng2022theantiferroptoticrole pages 3-3).<br />
- da Silva et al., 2024. Molecular characterization of iFSP1-like inhibitors; species selectivity considerations. (silva20242.4manuscriptiva pages 104-108).</p>
<p>Conclusion<br />
AIFM2/FSP1 is a human FAD-dependent, N-myristoylated membrane oxidoreductase that dimerizes to create dual active sites for quinone reduction and FAD hydroxylation. It suppresses ferroptosis by regenerating reduced CoQ and vitamin K hydroquinones at membranes, functioning in parallel to GPX4. Its activity and localization are governed by myristoylation and ubiquitination (e.g., RNF126), with structural data clarifying catalysis and emerging pharmacology (temsirolimus, iFSP1) enabling therapeutic strategies that combine FSP1 inhibition with GPX4 inhibitors or DNA repair modulators. Clinical-pathologic correlations support biomarker potential, and expert guidance underscores both promise and the need for careful risk management when translating ferroptosis therapies (lv2023structuralinsightsinto pages 1-2, doll2019fsp1isa pages 1-5, xie2024rnf126mediatedubiquitinationof pages 1-4, tian2024temsirolimusinhibitsfsp1 pages 2-5, deol2025vitaminb2metabolism pages 30-35, zeng2022theantiferroptoticrole pages 3-3, zeng2022theantiferroptoticrole pages 1-3).</p>
<p>References</p>
<ol>
<li>
<p>(lv2023structuralinsightsinto pages 1-2): Yun Lv, Chunhui Liang, Qichao Sun, Jing Zhu, Haiyan Xu, Xiaoqing Li, Yao-yao Li, Qihai Wang, Huiqing Yuan, Bo Chu, and Deyu Zhu. Structural insights into fsp1 catalysis and ferroptosis inhibition. Nature Communications, Sep 2023. URL: https://doi.org/10.1038/s41467-023-41626-7, doi:10.1038/s41467-023-41626-7. This article has 79 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(lv2023structuralinsightsinto pages 8-9): Yun Lv, Chunhui Liang, Qichao Sun, Jing Zhu, Haiyan Xu, Xiaoqing Li, Yao-yao Li, Qihai Wang, Huiqing Yuan, Bo Chu, and Deyu Zhu. Structural insights into fsp1 catalysis and ferroptosis inhibition. Nature Communications, Sep 2023. URL: https://doi.org/10.1038/s41467-023-41626-7, doi:10.1038/s41467-023-41626-7. This article has 79 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(doll2019fsp1isa pages 1-5): Sebastian Doll, Florencio Porto Freitas, Ron Shah, Maceler Aldrovandi, Milene Costa da Silva, Irina Ingold, Andrea Goya Grocin, Thamara Nishida Xavier da Silva, Elena Panzilius, Christina H. Scheel, Andr√© Mour√£o, Katalin Buday, Mami Sato, Jonas Wanninger, Thibaut Vignane, Vaishnavi Mohana, Markus Rehberg, Andrew Flatley, Aloys Schepers, Andreas Kurz, Daniel White, Markus Sauer, Michael Sattler, Edward William Tate, Werner Schmitz, Almut Schulze, Valerie O‚ÄôDonnell, Bettina Proneth, Grzegorz M. Popowicz, Derek A. Pratt, Jos√© Pedro Friedmann Angeli, and Marcus Conrad. Fsp1 is a glutathione-independent ferroptosis suppressor. Nature, 575:693-698, Oct 2019. URL: https://doi.org/10.1038/s41586-019-1707-0, doi:10.1038/s41586-019-1707-0. This article has 3034 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(doll2019fsp1isa pages 5-9): Sebastian Doll, Florencio Porto Freitas, Ron Shah, Maceler Aldrovandi, Milene Costa da Silva, Irina Ingold, Andrea Goya Grocin, Thamara Nishida Xavier da Silva, Elena Panzilius, Christina H. Scheel, Andr√© Mour√£o, Katalin Buday, Mami Sato, Jonas Wanninger, Thibaut Vignane, Vaishnavi Mohana, Markus Rehberg, Andrew Flatley, Aloys Schepers, Andreas Kurz, Daniel White, Markus Sauer, Michael Sattler, Edward William Tate, Werner Schmitz, Almut Schulze, Valerie O‚ÄôDonnell, Bettina Proneth, Grzegorz M. Popowicz, Derek A. Pratt, Jos√© Pedro Friedmann Angeli, and Marcus Conrad. Fsp1 is a glutathione-independent ferroptosis suppressor. Nature, 575:693-698, Oct 2019. URL: https://doi.org/10.1038/s41586-019-1707-0, doi:10.1038/s41586-019-1707-0. This article has 3034 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(deol2025vitaminb2metabolism pages 30-35): Kirandeep K. Deol, Cynthia A. Harris, Sydney J. Tomlinson, Cody E. Doubravsky, Alyssa J. Mathiowetz, and James A. Olzmann. Vitamin b2 metabolism promotes fsp1 stability to prevent ferroptosis. bioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.05.668752, doi:10.1101/2025.08.05.668752. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(zeng2022theantiferroptoticrole pages 1-3): Furong Zeng, Xiang Chen, and Guangtong Deng. The anti-ferroptotic role of fsp1: current molecular mechanism and therapeutic approach. Molecular Biomedicine, Nov 2022. URL: https://doi.org/10.1186/s43556-022-00105-z, doi:10.1186/s43556-022-00105-z. This article has 32 citations.</p>
</li>
<li>
<p>(doll2019fsp1isa pages 14-18): Sebastian Doll, Florencio Porto Freitas, Ron Shah, Maceler Aldrovandi, Milene Costa da Silva, Irina Ingold, Andrea Goya Grocin, Thamara Nishida Xavier da Silva, Elena Panzilius, Christina H. Scheel, Andr√© Mour√£o, Katalin Buday, Mami Sato, Jonas Wanninger, Thibaut Vignane, Vaishnavi Mohana, Markus Rehberg, Andrew Flatley, Aloys Schepers, Andreas Kurz, Daniel White, Markus Sauer, Michael Sattler, Edward William Tate, Werner Schmitz, Almut Schulze, Valerie O‚ÄôDonnell, Bettina Proneth, Grzegorz M. Popowicz, Derek A. Pratt, Jos√© Pedro Friedmann Angeli, and Marcus Conrad. Fsp1 is a glutathione-independent ferroptosis suppressor. Nature, 575:693-698, Oct 2019. URL: https://doi.org/10.1038/s41586-019-1707-0, doi:10.1038/s41586-019-1707-0. This article has 3034 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(xie2024rnf126mediatedubiquitinationof pages 1-4): Wanqun Xie, Jiajia Wang, Shuaiwei Tian, Heng Zhao, Liangliang Cao, Zhuangzhuang Liang, Jian Yang, Yang Zhao, Baocheng Wang, Feng Jiang, and Jie Ma. Rnf126-mediated ubiquitination of fsp1 affects its subcellular localization and ferroptosis. Oncogene, 43:1463-1475, Mar 2024. URL: https://doi.org/10.1038/s41388-024-02949-x, doi:10.1038/s41388-024-02949-x. This article has 15 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(deol2025vitaminb2metabolism pages 13-17): Kirandeep K. Deol, Cynthia A. Harris, Sydney J. Tomlinson, Cody E. Doubravsky, Alyssa J. Mathiowetz, and James A. Olzmann. Vitamin b2 metabolism promotes fsp1 stability to prevent ferroptosis. bioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.05.668752, doi:10.1101/2025.08.05.668752. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tian2024temsirolimusinhibitsfsp1 pages 2-5): Rui-Lin Tian, Tian-Xiang Wang, Zi-Xuan Huang, Zhen Yang, Kun-Liang Guan, Yue Xiong, Pu Wang, and Dan Ye. Temsirolimus inhibits fsp1 enzyme activity to induce ferroptosis and restrain liver cancer progression. Journal of Molecular Cell Biology, Sep 2024. URL: https://doi.org/10.1093/jmcb/mjae036, doi:10.1093/jmcb/mjae036. This article has 7 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(silva20242.4manuscriptiva pages 104-108): TNX da Silva, C Schulte, and AN Alves. 2.4 manuscript iv: molecular characterization of aifm2/fsp1 inhibition by ifsp1-like molecules. Unknown journal, 2024.</p>
</li>
<li>
<p>(zeng2022theantiferroptoticrole pages 3-3): Furong Zeng, Xiang Chen, and Guangtong Deng. The anti-ferroptotic role of fsp1: current molecular mechanism and therapeutic approach. Molecular Biomedicine, Nov 2022. URL: https://doi.org/10.1186/s43556-022-00105-z, doi:10.1186/s43556-022-00105-z. This article has 32 citations.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>lv2023structuralinsightsinto pages 1-2</li>
<li>zeng2022theantiferroptoticrole pages 1-3</li>
<li>zeng2022theantiferroptoticrole pages 3-3</li>
<li>lv2023structuralinsightsinto pages 8-9</li>
<li>https://doi.org/10.1038/s41467-023-41626-7</li>
<li>https://doi.org/10.1038/s41586-019-1707-0</li>
<li>https://doi.org/10.1038/s41580-024-00703-5;</li>
<li>https://doi.org/10.1038/s41556-024-01360-8</li>
<li>https://doi.org/10.1186/s43556-022-00105-z;</li>
<li>https://doi.org/10.1016/j.cmet.2023.06.014;</li>
<li>https://doi.org/10.1038/s41388-024-02949-x</li>
<li>https://doi.org/10.1101/2025.08.05.668752</li>
<li>https://doi.org/10.1186/s43556-022-00105-z</li>
<li>https://doi.org/10.1093/jmcb/mjae036</li>
<li>https://doi.org/10.3390/cancers16223888</li>
<li>https://doi.org/10.1038/s41418-024-01263-z</li>
<li>https://doi.org/10.1016/j.cmet.2023.06.014</li>
<li>https://doi.org/10.1038/s41580-024-00703-5</li>
<li>https://doi.org/10.1038/s41467-023-41626-7,</li>
<li>https://doi.org/10.1038/s41586-019-1707-0,</li>
<li>https://doi.org/10.1101/2025.08.05.668752,</li>
<li>https://doi.org/10.1186/s43556-022-00105-z,</li>
<li>https://doi.org/10.1038/s41388-024-02949-x,</li>
<li>https://doi.org/10.1093/jmcb/mjae036,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AIFM2-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9BRQ8" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2026-01-02T16:18:27.266352'<br />
end_time: '2026-01-02T16:20:14.864420'<br />
duration_seconds: 107.6<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AIFM2<br />
  gene_symbol: AIFM2<br />
  uniprot_accession: Q9BRQ8<br />
  protein_description: 'RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899,<br />
    ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900};<br />
    EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516};<br />
    AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer<br />
    of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907};<br />
    AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};'<br />
  gene_info: Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411};<br />
    Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the FAD-dependent oxidoreductase family.<br />
  protein_domains: FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2<br />
    (PF07992)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 49</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9BRQ8</li>
<li><strong>Protein Description:</strong> RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900}; EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516}; AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907}; Short=AMID {ECO:0000303|PubMed:11980907}; AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};</li>
<li><strong>Gene Information:</strong> Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411}; Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3 {ECO:0000303|PubMed:12135761};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the FAD-dependent oxidoreductase family.</li>
<li><strong>Key Domains:</strong> FAD/NAD-bd_sf. (IPR036188); FAD/NAD-binding_dom. (IPR023753); Pyr_redox_2 (PF07992)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AIFM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AIFM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AIFM2</strong> (gene ID: AIFM2, UniProt: Q9BRQ8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
The user is asking for a comprehensive research report on the AIFM2 gene (UniProt: Q9BRQ8) in humans. Let me verify the identity and then plan my research report.</p>
<p>From the context provided:<br />
- Gene: AIFM2 (also known as FSP1, AMID, PRG3)<br />
- UniProt: Q9BRQ8<br />
- Organism: Homo sapiens (Human)<br />
- Protein: Ferroptosis suppressor protein 1 (FSP1)<br />
- Key function: FAD-dependent oxidoreductase involved in ferroptosis suppression</p>
<p>The search results provided contain extensive information about AIFM2/FSP1. Let me plan my approach:</p>
<ol>
<li>Introduction - Define AIFM2/FSP1, historical context of its discovery</li>
<li>Molecular structure and domain organization</li>
<li>Biochemical function - detailed mechanistic understanding of what reactions it catalyzes</li>
<li>Cellular localization and membrane association</li>
<li>The ferroptosis suppression pathways (multiple mechanisms)</li>
<li>Gene expression regulation</li>
<li>Biological roles beyond ferroptosis suppression</li>
<li>Clinical and therapeutic implications</li>
<li>Conclusion</li>
</ol>
<p>Key themes from the search results to develop:<br />
- FSP1 as a parallel ferroptosis suppressor to GPX4<br />
- The FSP1-CoQ10-NAD(P)H pathway<br />
- N-myristoylation and membrane localization<br />
- Crystal structures revealing mechanism<br />
- Role in cancer cell survival and drug resistance<br />
- Multiple pathways of action (not just CoQ10)<br />
- Regulation by various transcription factors (Nrf2, p53)<br />
- Post-translational modifications</p>
<p>Let me structure this as a comprehensive 10,000+ word report with proper citations.<br />
</think></p>
<h1 id="aifm2-a-multifunctional-fad-dependent-oxidoreductase-with-central-roles-in-ferroptosis-suppression-and-cellular-metabolism">AIFM2: A Multifunctional FAD-Dependent Oxidoreductase with Central Roles in Ferroptosis Suppression and Cellular Metabolism</h1>
<p>This comprehensive report characterizes AIFM2 (apoptosis-inducing factor mitochondria-associated 2), a flavoprotein oxidoreductase encoded on human chromosome 10 that functions as the ferroptosis suppressor protein 1 (FSP1).[1][2] Recent discoveries have fundamentally revised our understanding of AIFM2's cellular roles, revealing that its primary function is not apoptosis induction, as originally proposed, but rather the suppression of ferroptosis through multiple distinct biochemical mechanisms.[1][3] This protein operates as a central metabolic enzyme in maintaining cellular redox homeostasis, and its dysregulation is implicated in cancer development, drug resistance, and metabolic disease. The following sections examine AIFM2's molecular structure, enzymatic mechanisms, cellular localization dynamics, regulation, and biological significance in detail.</p>
<h2 id="historical-discovery-and-nomenclature-of-aifm2">Historical Discovery and Nomenclature of AIFM2</h2>
<p>The AIFM2 gene was initially characterized as a p53-responsive gene designated PRG3 (p53-responsive gene 3) based on its induction under p53-dependent stress conditions.[2] Subsequently, the protein product was named apoptosis-inducing factor mitochondria-associated 2 (AIFM2) based on its structural homology to the apoptosis-inducing factor (AIF), leading to the presumption that it functioned as a pro-apoptotic protein similar to its homolog AIFM1.[2][4] However, this nomenclature proved misleading as functional studies demonstrated the opposite role. A pivotal 2019 study by Doll and colleagues employed expression cloning to identify genes capable of complementing GPX4 loss in human cancer cells and discovered that AIFM2 functioned as a ferroptosis suppressor, leading to its renaming as ferroptosis suppressor protein 1 (FSP1).[1] This protein is also known by the alternative designation AMID (apoptosis-inducing factor-homologous mitochondrion-associated inducer of death), a term reflecting the historical confusion regarding its biological function.[2] The renaming to FSP1 has become standard in contemporary literature reflecting the protein's true cellular role, though both designations appear interchangeably in scientific literature.</p>
<h2 id="molecular-structure-and-protein-architecture">Molecular Structure and Protein Architecture</h2>
<p>AIFM2 is a flavoprotein that encodes a multidomain oxidoreductase with a molecular weight of approximately 54 kilodaltons in its full-length form.[1][2] The protein architecture comprises several functionally distinct domains that collectively enable its enzymatic activity. The FAD-binding domain (FBD) occupies residues 12-141 and 241-318, harboring the critical flavin adenine dinucleotide cofactor essential for electron transfer reactions.[25][50] The NAD(P)H-binding domain (NBD) spans residues 142-240 and provides substrate recognition for the reduced nicotinamide adenine dinucleotide phosphate cofactor, which serves as the primary electron donor.[8][50] Critically, FSP1 displays strong selectivity for NADPH over NADH, with structural analysis revealing that the NAD(P)H-binding pocket of FSP1 is more positively charged than those of related proteins, enabling specific recognition of the negatively-charged phosphate group unique to NADPH through hydrogen bonding interactions with arginine residue R208.[8]</p>
<p>The C-terminal domain (CTD) spanning residues 319-373 serves as a distinctive structural feature unique to FSP1 among related oxidoreductases.[25][50] This domain contains intrinsically disordered regions (IDRs) capable of driving liquid-liquid phase separation and is absolutely essential for FSP1 function, as it mediates the formation of a functional homodimer required for catalytic activity.[6][25][50] Crystal structure analysis has demonstrated that the CTD enables the proper positioning of two active sites on opposite sides of the FAD molecule, one responsible for ubiquinone reduction and another for the unique FAD hydroxylation reaction that produces 6-hydroxy-FAD.[25][50] Deletion of the CTD results in complete loss of ferroptosis suppression activity despite preserved FAD and NAD(P)H binding, underscoring its critical role in catalytic function.[25]</p>
<p>The N-terminus of FSP1 contains a canonical myristoylation motif at glycine-2, where a myristic acid lipid group is covalently attached through post-translational modification.[1][2] This N-myristoylation is catalyzed by N-myristoyltransferase enzymes and is absolutely essential for the protein's anti-ferroptotic function, as myristoylation-deficient variants fail to suppress ferroptosis despite retaining enzymatic activity.[1][12] The myristoyl lipid moiety serves as a membrane-targeting signal that directs FSP1 to multiple cellular membranes including the plasma membrane and lipid droplets, where the protein's substrates are localized.[1][12][14] Recent evidence indicates that NADPH itself can promote N-myristoylation of FSP1 by interacting with N-myristoyltransferase 2 (NMT2), revealing an additional layer of regulation linking the protein's substrate abundance to its membrane recruitment.[14]</p>
<h2 id="enzymatic-mechanism-and-substrate-specificity">Enzymatic Mechanism and Substrate Specificity</h2>
<p>The primary biochemical function of AIFM2/FSP1 is catalysis of the NAD(P)H-dependent reduction of lipophilic quinone antioxidants, most prominently coenzyme Q10 (ubiquinone) and vitamin K.[1][2][8] This oxidoreductase activity operates through a classical two-electron transfer mechanism in which FSP1 catalyzes electron transfer from NADPH through the FAD prosthetic group to reduce the oxidized quinone substrate to its hydroquinone form (ubiquinol for CoQ10; VKH2 for vitamin K).[1][8][12] The kinetic parameters of this reaction have been characterized in detail, revealing a relatively low Km for ubiquinone analogs and a substantially higher Vmax compared to related oxidoreductases such as NQO1, indicating that FSP1 is highly optimized for efficient quinone reduction.[1][41]</p>
<p>Structural analysis of FSP1 bound to NADP+ and FAD demonstrates that the nicotinamide ring of NADPH forms a strong œÄ-œÄ interaction with the isoalloxazine ring of FAD, positioning the substrates for efficient electron transfer.[8] Biochemical studies have determined that FSP1 displays approximately 80-fold higher binding affinity for NADPH (Kd = 1.26 ¬± 0.29 ŒºM) compared to NADH, with the selectivity arising from specific hydrogen bonding interactions between the 2'-phosphate group of NADPH and positively charged residues in the binding pocket.[8] This NADPH-selective mechanism is physiologically significant, as NADPH levels are tightly regulated by cellular metabolic state and constitute the primary reducing equivalents available for antioxidant defense in the cytoplasm.[8]</p>
<p>A remarkable discovery from structural and biochemical studies is that FSP1 catalyzes production of 6-hydroxy-FAD, a modified flavin cofactor with potent antioxidant properties in its own right.[25] In the presence of oxygen and NADPH, FSP1 can catalyze hydroxylation of FAD at the 6-position of the isoalloxazine ring, producing 6-hydroxy-FAD which directly suppresses ferroptosis independently of quinone reduction.[25] The recombinant human FSP1 predominantly harbors 6-hydroxy-FAD as its flavin cofactor, suggesting that this modification occurs during protein folding and may represent an important in vivo form of the enzyme.[25] This FAD hydroxylation pocket is uniquely present in FSP1 among known NADH:quinone oxidoreductases and represents a distinctive catalytic capability that contributes to ferroptosis suppression through a mechanism separate from ubiquinone recycling.[25]</p>
<p>Regarding substrate specificity beyond CoQ10 and vitamin K, FSP1 does not reduce alternative substrates such as dehydroascorbate, oxidized glutathione, or tert-butyl hydroperoxide, demonstrating remarkable selectivity for lipophilic quinone antioxidants.[41] This specificity is critical for FSP1's unique physiological role, as it cannot substitute for the glutathione-dependent mechanisms that suppress ferroptosis through the canonical GPX4 pathway, instead operating as a genuinely parallel defense system.[1]</p>
<h2 id="cellular-localization-and-membrane-association-dynamics">Cellular Localization and Membrane Association Dynamics</h2>
<p>Unlike traditional mitochondrial proteins, AIFM2 lacks a recognizable mitochondrial targeting sequence and cannot enter the mitochondrial matrix.[2][7] Instead, the protein associates with the outer mitochondrial membrane (OMM) where it forms ring-like structures via its N-terminal hydrophobic domain.[2][7] The N-terminal myristoylation motif is essential for this OMM association, as myristoylation-deficient variants localize instead to the nucleus or diffusely throughout the cytoplasm and fail to exert ferroptosis suppression activity.[2][7]</p>
<p>The primary sites of FSP1 ferroptosis suppression activity are the plasma membrane and lipid droplets, reflecting where its lipophilic substrates (CoQ10 and vitamin K) are localized.[1][12][47] N-myristoylation-dependent recruitment of FSP1 to the plasma membrane represents the critical step for ferroptosis resistance, as membrane-localized FSP1 can directly access and reduce lipophilic quinone radicals propagating lipid peroxidation at the membrane interface.[1][47] Evidence from live-cell imaging demonstrates that NADPH supplementation significantly maintains FSP1 localization at the plasma membrane under ferroptotic stress conditions, with knockdown of FSP1 or inhibition with small-molecule FSP1 inhibitors causing redistribution of the protein from the membrane to intracellular condensates.[14][26]</p>
<p>In brown adipose tissue specifically, AIFM2 exhibits a distinct subcellular localization pattern, initially associating with lipid droplets under basal conditions and undergoing cold-induced translocation to the mitochondrial inner membrane upon Œ≤-adrenergic stimulation.[10][55] This tissue-specific relocalization is mediated by the N-terminal myristoylation motif, as myristoylation-deficient variants localize exclusively to mitochondria under all conditions.[10] During cold-induced thermogenesis, AIFM2 translocates from lipid droplets to the mitochondrial inner membrane-facing intermembrane space, where it catalyzes oxidation of cytosolic NADH to regenerate NAD+ for sustained glycolysis and thermogenesis.[10][55] This dynamic relocalization represents a specialized metabolic function distinct from AIFM2's canonical ferroptosis suppression role and illustrates the functional versatility of this multifunctional oxidoreductase.</p>
<h2 id="the-fsp1-coq10-nadph-ferroptosis-suppression-pathway">The FSP1-CoQ10-NAD(P)H Ferroptosis Suppression Pathway</h2>
<p>The primary mechanism by which AIFM2/FSP1 suppresses ferroptosis involves recycling of oxidized coenzyme Q10 (ubiquinone) to its reduced form (ubiquinol), which functions as a lipophilic radical-trapping antioxidant (RTA).[1][3] Ferroptosis is characterized by lethal accumulation of lipid peroxides in cellular membranes, particularly in polyunsaturated fatty acid-containing phospholipids.[1][3] The propagation of lipid peroxidation proceeds through radical chain reactions in which lipid peroxyl radicals (LOO‚Ä¢) abstract hydrogen atoms from neighboring lipids, producing additional peroxides and perpetuating membrane damage.[1]</p>
<p>Ubiquinol, the reduced form of CoQ10, directly intercepts these propagating lipid peroxyl radicals through hydrogen atom donation, converting lipid peroxyl radicals to relatively stable lipid hydroperoxides and reducing the ubiquinol to ubiquinone in the process.[1][47] However, ubiquinone is readily re-oxidized during lipid peroxidation, requiring continuous regeneration to maintain radical scavenging capacity. FSP1 catalyzes this critical regeneration step using NADPH as the reducing substrate, thereby maintaining a continuous cycling of CoQ10 between its inactive ubiquinone and active ubiquinol forms.[1][3] This FSP1-mediated recycling of CoQ10 operates in parallel to the canonical glutathione-dependent ferroptosis suppression system centered on GPX4, such that both pathways must be simultaneously inhibited to effectively induce ferroptosis in many cancer cell types.[1][3]</p>
<p>The physiological relevance of the FSP1-CoQ10 pathway is demonstrated by the fact that cells completely dependent on ubiquinol-mediated ferroptosis suppression due to CoQ2 knockout cannot be rescued by FSP1 overexpression, confirming that CoQ10 biosynthesis is an absolute requirement for FSP1-mediated ferroptosis suppression.[41] Conversely, CoQ10 levels only modestly affect ferroptosis sensitivity compared to FSP1 expression, indicating that FSP1's enzymatic activity to efficiently regenerate ubiquinol is the rate-limiting component of this ferroptosis defense mechanism.[41]</p>
<p>Consistent with its role as a stand-alone parallel system, genetic or pharmacological FSP1 inhibition synergizes powerfully with GPX4 inhibitors to trigger ferroptosis in cancer cells that would otherwise be refractory to single-pathway inhibition.[1][3] Clinical and preclinical studies have identified FSP1 expression as a strong predictor of resistance to ferroptosis-inducing agents across multiple cancer types, with high FSP1 expression strongly correlating with poor treatment outcomes and accelerated tumor progression.[3][6][29]</p>
<h2 id="the-fsp1-vitamin-k-nadph-pathway">The FSP1-Vitamin K-NAD(P)H Pathway</h2>
<p>Beyond CoQ10 reduction, AIFM2/FSP1 catalyzes reduction of vitamin K (phylloquinone, menaquinone-4, and menadione) to its hydroquinone form (VKH2), which similarly functions as a potent lipophilic radical-trapping antioxidant.[2][12][47] A genome-wide CRISPR knockout screen employing a vitamin K-dependent carboxylation reporter identified FSP1 as the enzyme responsible for warfarin-resistant vitamin K reduction, a phenomenon clinically relevant to patients on anticoagulant therapy.[13] The vitamin K hydroquinone produced by FSP1 suppresses lipid peroxidation through identical mechanisms to ubiquinol, directly intercepting and neutralizing lipid peroxyl radicals while being oxidized to vitamin K epoxide in the process.[16][47]</p>
<p>The FSP1-mediated vitamin K cycle operates independently of the canonical vitamin K oxidoreductase VKORC1, which reduces vitamin K epoxide to quinone and serves the classical role of supporting vitamin K-dependent protein carboxylation in the clotting cascade.[13][51] FSP1 specifically catalyzes the warfarin-resistant reduction of oxidized vitamin K to its fully reduced hydroquinone form, a function that VKORC1 cannot efficiently perform.[13] This distinction is clinically significant, as FSP1 inhibition would not only suppress ferroptosis but also impair vitamin K-dependent protein carboxylation, representing a potential adverse effect of FSP1-targeting therapeutics that must be carefully managed.[13]</p>
<h2 id="the-fsp1-escrt-iii-membrane-repair-pathway">The FSP1-ESCRT-III Membrane Repair Pathway</h2>
<p>A second mechanism of FSP1-mediated ferroptosis suppression distinct from quinone antioxidant recycling involves engagement of the endosomal sorting complexes required for transport (ESCRT)-III machinery for plasma membrane repair.[9][15][47] Evidence for this mechanism emerged from studies showing that AIFM2 suppresses ferroptotic cancer cell death through a mechanism that is independent of ubiquinol metabolism, as demonstrated in cells with knockout of CoQ2 (the first enzyme in CoQ10 biosynthesis) that cannot synthesize endogenous ubiquinone.[9] In these cells, AIFM2 nonetheless suppresses ferroptosis, indicating an alternative mechanism of action.</p>
<p>Mechanistic studies revealed that AIFM2 recruits charged multivesicular body protein 5 (CHMP5) and CHMP6, critical ESCRT-III subunits involved in membrane scission and repair, to the plasma membrane where ferroptotic damage is occurring.[9][47] Knockdown of FSP1 suppresses CHMP5 and CHMP6 membrane localization, while overexpression of these ESCRT components rescues ferroptosis resistance in FSP1-deficient cells.[47] This ESCRT-III-dependent membrane repair mechanism operates through regulated membrane budding and fission, enabling cells to physically isolate damaged membrane regions before lethal membrane permeabilization occurs.[9][47]</p>
<p>The relative contributions of the quinone-recycling and ESCRT-III membrane repair mechanisms to FSP1-mediated ferroptosis suppression likely vary depending on cellular context and the specific ferroptotic stimulus employed. Both mechanisms represent legitimate, non-redundant pathways through which FSP1 suppresses ferroptosis, and optimal FSP1 inhibition for therapeutic purposes may need to target both mechanisms simultaneously to achieve maximal ferroptosis induction.</p>
<h2 id="fsp1-regulation-at-multiple-levels-of-gene-expression">FSP1 Regulation at Multiple Levels of Gene Expression</h2>
<p>AIFM2/FSP1 expression is dynamically regulated at transcriptional, post-transcriptional, and post-translational levels, allowing rapid modulation of ferroptosis suppression capacity in response to cellular stress and metabolic state. At the transcriptional level, the FSP1 promoter is a direct target of nuclear factor erythroid 2-related factor 2 (NRF2), a master transcription factor controlling cellular antioxidant responses.[6][12][35] Under oxidative stress conditions, NRF2 translocates to the nucleus and binds antioxidant response elements (AREs) in the FSP1 promoter, directly upregulating FSP1 expression as part of the coordinated antioxidant gene response.[6][35] This transcriptional regulation is particularly prominent in KEAP1-deficient cancers, where constitutive NRF2 stabilization drives high FSP1 expression that confers ferroptosis resistance and radioresistance.[35]</p>
<p>Additionally, the AIFM2 gene contains a putative p53-binding element in intron 5, indicating that p53, the canonical tumor suppressor, can activate FSP1 expression under stress conditions.[2][4] This p53-dependent regulation is paradoxical given that p53 typically functions to induce apoptosis and ferroptosis as tumor-suppressive mechanisms. However, in certain contexts p53 activation may trigger FSP1 upregulation to allow cells to survive immediate stress, possibly facilitating subsequent adaptation mechanisms.[21] The ATF6-p53-AIFM2 axis has been implicated in endoplasmic reticulum stress responses, with ATF6 activation promoting AIFM2 transcription through p53-dependent mechanisms in the context of severe acute pancreatitis.[21]</p>
<p>Post-transcriptional regulation involves microRNA-mediated control and mRNA stability mechanisms, with miR-4443 inhibiting AIFM2 expression through suppression of m6A methylation (via METTL3), while the acetyltransferase NAT10 enhances mRNA stability through ac4C modification.[6] These epitranscriptomic modifications provide rapid mechanisms to modulate FSP1 protein synthesis in response to metabolic demands.[6]</p>
<p>Post-translational modifications provide the most rapid mechanisms for modulating FSP1 activity. The E3 ubiquitin ligase TRIM21 mediates K63-linked ubiquitination of FSP1, facilitating its translocation to the plasma membrane where it exerts maximal anti-lipid peroxidation activity, thereby enhancing ferroptosis resistance.[6] Conversely, the deubiquitinase USP7 opposes TRIM21-mediated ubiquitination, reducing FSP1 membrane localization and ferroptosis suppression capacity.[6] Acetylation at lysine residues has been reported to stabilize FSP1 protein by preventing ubiquitin-mediated degradation, offering another regulatory point.[45] Furthermore, accumulation of lipid droplets can sequester FSP1 and influence its subcellular availability for ferroptosis suppression, providing a link between lipid metabolism and ferroptosis sensitivity.[6]</p>
<h2 id="small-molecule-inhibitors-of-fsp1-and-their-mechanisms">Small-Molecule Inhibitors of FSP1 and Their Mechanisms</h2>
<p>Discovery of selective small-molecule FSP1 inhibitors has enabled mechanistic studies of FSP1-mediated ferroptosis suppression and represents a promising therapeutic strategy for overcoming ferroptosis resistance in cancer. The first-described FSP1 inhibitor, designated iFSP1, functions as a competitive inhibitor that directly occupies the substrate-binding pocket of FSP1 and prevents reduction of CoQ10 and vitamin K substrates.[1][41][38] Pharmacological screening has subsequently identified FSEN1 as a more selective and potent FSP1 inhibitor with superior cellular efficacy.[3][29]</p>
<p>The crystal structure of human FSP1 bound to the inhibitor FSEN1 has been solved, revealing that FSEN1 binds within the FSP1 substrate-binding pocket through multiple interactions.[3][29] The phenyl ring of FSEN1 forms a critical œÄ-œÄ stacking interaction with phenylalanine-360 of FSP1, with this F360 residue being absolutely essential for FSEN1 binding and inhibition.[3][29] The bromo group of FSEN1 forms hydrogen bonds with threonine-363 and serine-364, while the tail group interacts hydrophobically with multiple FSP1 residues including T327, L329, I341, M350, and T354.[3][29] Mutagenesis studies confirm that F360A or double mutations of T363/S364 substantially reduce FSEN1 inhibition, validating the structural findings.[3][29]</p>
<p>Notably, FSEN1 exhibits species selectivity, functioning as a potent inhibitor of human FSP1 but not mouse FSP1, due to a critical leucine residue at position 360 in mouse FSP1 instead of the phenylalanine found in human FSP1.[3][29] This species selectivity has enabled development of humanized mouse models wherein human FSP1 is expressed, allowing in vivo testing of FSEN1 efficacy. Enzyme kinetic analysis reveals that FSEN1 functions as an uncompetitive inhibitor, meaning it binds to the FSP1-substrate complex after substrates have bound to FSP1, rather than competing with substrates for direct binding.[38] This uncompetitive mechanism indicates that FSEN1 requires prior substrate binding to FSP1 for inhibitor binding, explaining why FSEN1 shows dramatic synergy with GPX4 inhibitors in triggering ferroptosis, as GPX4 inhibition creates a cellular state highly dependent on FSP1 activity.[38]</p>
<p>An alternative FSP1 inhibitor designated icFSP1 has been discovered that functions through a distinct mechanism: rather than competitively inhibiting FSP1 enzymatic activity, icFSP1 induces subcellular relocalization and phase separation of FSP1 from membranes into intracellular condensate droplets.[26] This phase separation-based inhibition mechanism prevents FSP1 from maintaining its functional position at the plasma membrane and lipid droplets, thereby disrupting its capacity to suppress lipid peroxidation despite the enzyme retaining catalytic activity.[26] This discovery reveals that FSP1 localization, which depends on N-myristoylation and regulated membrane association, constitutes a therapeutic vulnerability independent of direct enzymatic inhibition.[26]</p>
<h2 id="roles-of-aifm2fsp1-beyond-ferroptosis-suppression">Roles of AIFM2/FSP1 Beyond Ferroptosis Suppression</h2>
<p>While ferroptosis suppression represents the canonical cellular function of AIFM2/FSP1, mounting evidence indicates additional physiological roles for this multifunctional oxidoreductase, particularly in metabolic regulation and cancer cell biology distinct from ferroptosis control.</p>
<h3 id="aifm2-in-brown-adipose-tissue-thermogenesis">AIFM2 in Brown Adipose Tissue Thermogenesis</h3>
<p>A specialized role for AIFM2 in brown adipose tissue (BAT) involves its participation in thermogenesis and energy expenditure.[10][55] AIFM2 is highly and specifically expressed in brown adipocytes, where it localizes to lipid droplets under basal conditions.[10][55] Upon cold exposure or Œ≤-adrenergic stimulation, AIFM2 rapidly translocates from lipid droplets to the mitochondrial inner membrane facing the intermembrane space, where it catalyzes oxidation of cytosolic NADH to regenerate NAD+.[10][55] This NADH oxidation activity is essential for maintaining robust glycolysis in BAT cells during thermogenesis, as the regeneration of NAD+ is the rate-limiting step for continued glycolytic flux when mitochondrial oxidative phosphorylation is partially uncoupled.[10][55]</p>
<p>The metabolic significance of AIFM2 in BAT is demonstrated by the fact that AIFM2 overexpression enhances oxygen consumption, uncoupled respiration, and heat production during cold-induced thermogenesis.[10][55] Conversely, knockdown of AIFM2 impairs glucose-dependent thermogenesis and reduces mitochondrial membrane potential and electron transport chain activity.[10][55] This role in thermogenesis identifies AIFM2 as a potential target for therapeutic modulation of energy expenditure in the context of obesity and metabolic disease.[10][55]</p>
<h3 id="aifm2-in-cancer-cell-metabolism-and-drug-resistance">AIFM2 in Cancer Cell Metabolism and Drug Resistance</h3>
<p>Beyond ferroptosis suppression, AIFM2/FSP1 has been implicated in promoting epithelial-mesenchymal transition (EMT), a process central to cancer metastasis and chemotherapy resistance.[6][32] High FSP1 expression maintains a low lipid-reactive oxygen species milieu that stabilizes EMT transcription factors Snail and Slug, downregulates epithelial marker E-cadherin, and upregulates mesenchymal markers Vimentin and N-cadherin.[6] These FSP1-dependent changes promote an invasive, metastatic phenotype independent of ferroptosis control.[6][32] In triple-negative breast cancer cells, FSP1 is critically important for tumor cell survival under hypoxic and nutrient-limited conditions characteristic of the tumor microenvironment, reflecting the high intracellular iron content and limited antioxidant capacity of these cells.[6]</p>
<p>In the context of drug-tolerant persisters (DTPs)‚Äîa population of cancer cells that survive chemotherapy and serve as a reservoir for disease recurrence‚ÄîFSP1 expression is markedly elevated.[32][56] High FSP1 correlates with poor survival following chemotherapy and predicts development of drug resistance through effects on iron homeostasis and lipid metabolism distinct from ferroptosis suppression.[32][56] FSP1 promotes mitochondrial biogenesis through activation of the SIRT1/PGC-1Œ± axis, enhancing metabolic capacity and invasive potential of tumor cells.[6] In pancreatic ductal adenocarcinoma cells harboring KRAS mutations, FSP1-mediated ferroptosis suppression is crucial for cell survival, with FSP1 overexpression enhancing cellular resistance to lipid peroxidation and promoting organoid formation and tumor initiation.[6][59]</p>
<h3 id="aifm2-dna-binding-and-chromatin-regulation">AIFM2-DNA Binding and Chromatin Regulation</h3>
<p>In addition to its oxidoreductase function, AIFM2 possesses intrinsic DNA-binding capacity and has been shown to interact directly with nuclear DNA in a non-sequence-specific manner.[2][19] Under oxidative stress conditions, reactive aldehyde species such as 4-hydroxy-2-nonenal (4HNE) form adducts with critical cysteine and lysine residues on AIFM2, diminishing its NADH oxidoreductase function while promoting its translocation from mitochondria to the nucleus.[2][19][34] This nuclear-localized, DNA-binding form of AIFM2 has been implicated in facilitating apoptosis in cardiac tissue during doxorubicin-induced cardiotoxicity.[34][39]</p>
<p>DNA binding appears to suppress AIFM2's redox activity through mutually exclusive binding of DNA and the NAD(P)H cofactor.[19] This DNA-binding activity contributes to AIFM2's involvement in apoptotic responses to viral and bacterial infections, possibly through its role in reactive oxygen species regulation and ROS-dependent signaling pathways.[2][19] The biological significance of AIFM2 DNA binding in ferroptosis suppression remains unclear, though it may represent a regulatory mechanism to modulate redox activity under conditions of extreme oxidative stress.</p>
<h2 id="aifm2-expression-across-tissues-and-cancer-types">AIFM2 Expression Across Tissues and Cancer Types</h2>
<p>AIFM2 mRNA expression patterns vary substantially across human tissues, with highest expression detected in cardiac tissue, followed by liver and skeletal muscle, with lower expression in lung, kidney, and pancreas, and minimal expression in brain tissue.[2][4] This tissue-specific expression pattern suggests differential dependence of various tissues on AIFM2 for ferroptosis suppression and metabolic regulation. The apparent exception is the brain, where AIFM2 expression is very low despite neurons being vulnerable to ferroptosis-induced death, suggesting alternative ferroptosis suppression mechanisms in neural tissue or a specialized neuroprotective role for AIFM2.[2]</p>
<p>In cancer tissues, AIFM2 mRNA levels are often downregulated compared to normal tissues, yet high FSP1 protein expression is selected for during cancer development, particularly in tumors with KEAP1 mutations or those subjected to chemotherapy.[27][31][35] This apparent paradox may reflect post-transcriptional and post-translational regulatory mechanisms that increase FSP1 protein stability and activity in the cancer context. High AIFM2/FSP1 expression is associated with poor prognosis in acute myeloid leukemia, with elevated FSP1 conferring ferroptosis resistance that enables leukemic cell survival.[27]</p>
<h2 id="therapeutic-implications-and-fsp1-targeting-strategies">Therapeutic Implications and FSP1-Targeting Strategies</h2>
<p>The discovery of FSP1 as a major ferroptosis suppressor has opened a new therapeutic avenue for cancer treatment, particularly in tumors that are refractory to conventional ferroptosis inducers targeting the GPX4 pathway.[1][3][29] Pharmacological inhibition of FSP1 strongly synergizes with GPX4 inhibitors, triggering ferroptosis in a wide range of cancer cell lines and suppressing tumor growth in preclinical xenograft models.[1][3][29] FSP1 inhibition has been shown to sensitize hepatocellular carcinoma models to ferroptosis while simultaneously reshaping the tumor immune microenvironment by enhancing damage-associated molecular pattern (DAMP) release.[6]</p>
<p>One potential challenge in FSP1-targeted therapeutics is that FSP1 inhibition may impair vitamin K-dependent protein carboxylation, affecting the hemostasis system and potentially other vitamin K-dependent physiological processes.[13] This adverse effect must be carefully evaluated during clinical development of FSP1 inhibitors, potentially requiring combination strategies with vitamin K supplementation or selective targeting of FSP1 inhibition to particular tissues or cellular contexts where ferroptosis induction is therapeutically beneficial while minimizing systemic anticoagulant effects.</p>
<p>The exquisite selectivity of FSEN1 for human FSP1 over mouse FSP1 has enabled development of humanized preclinical models for evaluating FSP1 inhibitor efficacy and toxicity.[3][29] These models will be essential for translating FSP1-targeting therapeutics to clinical use while managing potential off-target or adverse effects of prolonged FSP1 inhibition.</p>
<h2 id="conclusion">Conclusion</h2>
<p>AIFM2, renamed ferroptosis suppressor protein 1 (FSP1), has emerged as a central regulator of ferroptosis suppression and cellular metabolism in human cells. This multifunctional FAD-dependent oxidoreductase catalyzes NAD(P)H-dependent reduction of lipophilic quinone antioxidants, particularly coenzyme Q10 and vitamin K, generating active radical-trapping antioxidants that suppress lipid peroxidation and ferroptosis.[1][3] FSP1 additionally suppresses ferroptosis through ESCRT-III-dependent membrane repair mechanisms independent of quinone recycling.[9][47] The protein's catalytic activity, membrane localization, and expression level are tightly regulated through transcriptional mechanisms involving NRF2 and p53, post-transcriptional mechanisms involving microRNAs and epitranscriptomic modifications, and post-translational modifications including ubiquitination and acetylation.[6][12] Beyond ferroptosis suppression, FSP1 participates in brown adipose tissue thermogenesis, cancer cell metabolic reprogramming, and epithelial-mesenchymal transition, revealing its roles as a multifaceted metabolic enzyme.[10][32][55]</p>
<p>The identification of small-molecule FSP1 inhibitors including FSEN1 and icFSP1 has validated FSP1 as a therapeutic target for overcoming ferroptosis-resistant cancers.[3][26][29][38] However, the pleiotrophic metabolic roles of FSP1 and its requirement for vitamin K-dependent protein carboxylation necessitate careful clinical development to maximize therapeutic benefit while minimizing systemic adverse effects. Future research should focus on understanding the relative contributions of FSP1's multiple ferroptosis suppression mechanisms in different cellular and tissue contexts, developing tissue-selective FSP1 inhibitors, and determining the optimal therapeutic strategies for combining FSP1 inhibition with established cancer therapies. The structural and mechanistic insights gained from FSP1 studies will likely inform development of inhibitors targeting related oxidoreductases and advance our understanding of how cellular metabolism intersects with regulated cell death pathways to control cancer progression and cellular fate.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://pubmed.ncbi.nlm.nih.gov/31634899/</li>
<li>https://learn.mapmygenome.in/aifm2</li>
<li>https://www.pnas.org/doi/10.1073/pnas.2505197122</li>
<li>https://en.wikipedia.org/wiki/AIFM2</li>
<li>https://www.proteinatlas.org/ENSG00000042286-AIFM2</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12384476/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10709417/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/31964528/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7031813/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12146761/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11228423/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9929328/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11074979/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11673384/</li>
<li>https://pubs.acs.org/doi/10.1021/jacs.5c15621</li>
<li>https://maayanlab.cloud/Harmonizome/gene/AIFM2</li>
<li>https://www.pnas.org/doi/10.1073/pnas.1017547108</li>
<li>https://www.thno.org/v10p8298.htm</li>
<li>https://pubmed.ncbi.nlm.nih.gov/17711848/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7812130/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/32724472/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10516921/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10338336/</li>
<li>https://www.aging-us.com/article/205257/text</li>
<li>https://www.tandfonline.com/doi/full/10.1080/10495398.2024.2377209</li>
<li>https://www.aging-us.com/article/205409/text</li>
<li>https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.809952/full</li>
<li>https://www.ahajournals.org/doi/10.1161/res.127.suppl_1.204</li>
<li>https://www.oncotarget.com/article/28301/pdf/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11574213/</li>
<li>https://www.ncbi.nlm.nih.gov/gene/84883</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10524360/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10641738/</li>
<li>https://www.uniprot.org/uniprotkb/Q9BRQ8/entry</li>
<li>https://orca.cardiff.ac.uk/id/eprint/126674/1/FSP1%20is%20a%20glutathione%20independent%20VOD.pdf</li>
<li>https://aacrjournals.org/clincancerres/article/24/7/1644/81221/Extracellular-Vesicles-Released-by-Cardiomyocytes</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10840079/</li>
<li>https://www.uniprot.org/uniprotkb/B5FXE5/entry</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9708954/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8946176/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7169958/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6014353/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2814075/</li>
<li>https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.479</li>
<li>https://www.ccjm.org/content/ccjom/76/12/724.full.pdf</li>
<li>https://platform.opentargets.org/target/ENSG00000042286/associations</li>
<li>https://www.ijbs.com/v18p6176.pdf</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11345167/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4761499/</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9BRQ8
gene_symbol: AIFM2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: FSP1 (Ferroptosis Suppressor Protein 1, formerly AMID/PRG3) is an FAD-dependent,
  N-myristoylated membrane oxidoreductase that functions as a major glutathione-independent
  suppressor of ferroptosis. FSP1 catalyzes the NAD(P)H-dependent reduction of ubiquinone
  (CoQ10) to ubiquinol and vitamin K to its hydroquinone form (VKH2), both of which
  act as potent radical-trapping antioxidants to prevent phospholipid peroxidation
  at cellular membranes. FSP1 operates in parallel to GPX4 as a second major defense
  against ferroptosis. N-myristoylation targets FSP1 to the plasma membrane and lipid
  droplets where it performs its anti-ferroptotic function. The original characterization
  as a pro-apoptotic factor (AMID) from early studies has been largely superseded
  by the discovery of its primary role in ferroptosis suppression.
existing_annotations:
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: FSP1 is now recognized as the primary glutathione-independent ferroptosis
      suppressor, acting in parallel to GPX4 (PMID:31634899, PMID:31634900). This
      function was definitively established in 2019 and represents the core biological
      role of the protein. The IBA annotation from phylogenetic inference is consistent
      with extensive experimental evidence.
    action: ACCEPT
    reason: This is the primary biological function of FSP1. Multiple high-quality
      studies demonstrate that FSP1 suppresses ferroptosis by regenerating ubiquinol
      and vitamin K hydroquinone as radical-trapping antioxidants (PMID:31634899,
      PMID:31634900, PMID:35922516).
    additional_reference_ids:
    - PMID:39313331
    - PMID:38514855
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: the flavoprotein apoptosis-inducing factor mitochondria-associated
        2 (AIFM2) is a previously unrecognized anti-ferroptotic gene
    - reference_id: PMID:31634900
      supporting_text: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
        ferroptosis
    - reference_id: file:human/AIFM2/AIFM2-deep-research-falcon.md
      supporting_text: renamed ferroptosis suppressor protein 1 (FSP1) for its role
        in suppressing ferroptosis independently of GPX4
    - reference_id: PMID:39313331
      supporting_text: temsirolimus sensitized liver cancer cells to ferroptosis by
        directly binding to and inhibiting ferroptosis suppressor protein 1 (FSP1)
        enzyme
    - reference_id: PMID:38514855
      supporting_text: The RNF126-FSP1-CoQ10 pathway plays a pivotal role in suppressing
        phospholipid peroxidation and ferroptosis both in vivo and in vitro
- term:
    id: GO:0008637
    label: apoptotic mitochondrial changes
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &#39;This annotation derives from the early characterization of AIFM2 as
      AMID in 2002 (PMID:11980907), before the discovery of ferroptosis and FSP1&#39;&#39;s
      primary role. UniProt notes explicitly: &#34;Conflicting data exist on the pro-apoptotic
      function of the protein. It was initially claimed that overexpression of FSP1
      induces caspase-independent apoptosis, but new evidence disputes this function.&#34;&#39;
    action: KEEP_AS_NON_CORE
    reason: While overexpression studies showed apoptotic phenotypes (PMID:11980907),
      this likely represents an artifact of overexpression or a minor function. The
      primary function of FSP1 is now firmly established as ferroptosis suppression.
      However, some literature suggests FSP1 may have context-dependent roles in cell
      death pathways, so complete removal is not warranted.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: Overexpression of AMID induced cell death with characteristic
        apoptotic morphology
- term:
    id: GO:0031966
    label: mitochondrial membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Early studies localized AMID to mitochondria (PMID:11980907), hence the
      name &#34;mitochondrion-associated.&#34; However, the current understanding is that
      FSP1 primarily localizes to the plasma membrane and lipid droplets via N-myristoylation,
      where it performs its anti-ferroptotic function (PMID:31634899, PMID:31634900).
      The mitochondrial localization may represent a minor pool or overexpression
      artifact.
    action: KEEP_AS_NON_CORE
    reason: While some studies showed mitochondrial localization, the primary functional
      location of FSP1 is at the plasma membrane and lipid droplets. The N-myristoylation
      that targets FSP1 to membranes is essential for its anti-ferroptotic function.
      Mitochondrial association may be context-dependent or represent a minor pool.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: myristoylation recruits FSP1 to the plasma membrane where it
        functions as an oxidoreductase that reduces coenzyme Q10
- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: This annotation from phylogenetic inference reflects the early AMID characterization
      (PMID:11980907, PMID:12135761). UniProt explicitly notes conflicting data on
      the pro-apoptotic function. The overexpression-based pro-apoptotic phenotype
      has not been validated as a physiological function, and FSP1&#39;s primary role
      is now established as ANTI-ferroptotic (which prevents a form of cell death).
    action: MARK_AS_OVER_ANNOTATED
    reason: The pro-apoptotic function was based on overexpression studies from 2002
      before ferroptosis was discovered. Current understanding is that FSP1 prevents
      cell death by suppressing ferroptosis. The apoptotic function is disputed in
      the literature and likely represents an overexpression artifact.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: Overexpression of AMID induced cell death with characteristic
        apoptotic morphology
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: FSP1 is present in the cytoplasm (PMID:12135761, UniProt confirmed).
      This is consistent with its role as a soluble oxidoreductase that can be recruited
      to membranes via N-myristoylation.
    action: ACCEPT
    reason: Cytoplasmic localization is well-supported and represents the non-membrane-bound
      pool of FSP1. Multiple studies confirm cytoplasmic presence.
    supported_by:
    - reference_id: PMID:12135761
      supporting_text: PRG3 localizes in the cytoplasm
- term:
    id: GO:0004174
    label: electron-transferring-flavoprotein dehydrogenase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: This GO term (GO:0004174) refers to the specific activity of electron
      transfer from electron-transferring flavoprotein (ETF) to ubiquinone in the
      mitochondrial electron transport chain. FSP1 is NOT part of the mitochondrial
      electron transport chain and does not interact with ETF. FSP1 is a CoQ/vitamin
      K reductase that acts at the plasma membrane, not in mitochondrial respiration.
    action: MODIFY
    reason: GO:0004174 is the incorrect term for FSP1&#39;s activity. FSP1 reduces ubiquinone
      directly using NAD(P)H, not via ETF. The correct term is GO:0016655 &#34;oxidoreductase
      activity, acting on NAD(P)H, quinone or similar compound as acceptor&#34; which
      precisely describes FSP1&#39;s catalytic mechanism.
    proposed_replacement_terms:
    - id: GO:0016655
      label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
        as acceptor
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: FSP1 catalyses the regeneration of CoQ10 using NAD(P)H
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: FSP1 binds a modified FAD cofactor (6-hydroxy-FAD) non-covalently (PMID:15958387).
      Structural studies of chicken FSP1 revealed the carboxy-terminal domain mediates
      functional dimerization and the formation of two active sites on either side
      of the FAD (PMID:37739943). The 6-hydroxy-FAD is both an active cofactor and
      itself an anti-ferroptotic compound.
    action: ACCEPT
    reason: FAD binding is a core feature of FSP1 required for its oxidoreductase
      activity. The protein binds 6-hydroxy-FAD as its cofactor. Structural studies
      confirm the FAD-binding domain as essential for the homodimer assembly and catalytic
      activity.
    supported_by:
    - reference_id: PMID:15958387
      supporting_text: AMID binds 6-hydroxy-FAD (a cofactor that accumulates only
        adventitiously and at low abundance in other flavoprotein enzymes) to form
        a stoichiometric cofactor.protein complex
    - reference_id: PMID:37739943
      supporting_text: the carboxy-terminal domain is crucial for the catalytic activity
        and ferroptosis inhibition of FSP1 by mediating the functional dimerization
        of FSP1, and the formation of two active sites located on two sides of FAD
- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: DNA binding was demonstrated biochemically in PMID:15958387, showing
      non-sequence specific binding. However, this is not considered the core function
      of FSP1 and its physiological relevance is unclear. UniProt notes this activity.
    action: KEEP_AS_NON_CORE
    reason: While DNA binding was demonstrated in vitro, its physiological relevance
      is unclear. The primary function of FSP1 is as a membrane oxidoreductase suppressing
      ferroptosis, not DNA binding.
    supported_by:
    - reference_id: PMID:15958387
      supporting_text: AMID is a DNA-binding protein that lacks apparent DNA sequence
        specificity
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Nuclear localization was reported in the context of oxidative stress
      signaling (PMID:26689472). Upon oxidative stress, FSP1 modified by 4-hydroxynonenal
      translocates to the nucleus. This is not the primary localization.
    action: KEEP_AS_NON_CORE
    reason: Nuclear localization occurs under specific stress conditions and is not
      the primary functional location. The plasma membrane and lipid droplets are
      the primary sites of FSP1 activity.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate of earlier cytoplasm annotation. Cytoplasmic localization is
      confirmed.
    action: ACCEPT
    reason: Cytoplasmic localization is well-supported by multiple studies.
- term:
    id: GO:0005811
    label: lipid droplet
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: FSP1 localizes to lipid droplets via N-myristoylation (PMID:31634900,
      PMID:14741744). This is a core functional localization site.
    action: ACCEPT
    reason: Lipid droplet localization is a primary site where FSP1 performs its anti-ferroptotic
      function by regenerating reduced quinones to prevent lipid peroxidation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: Plasma membrane is the PRIMARY functional location of FSP1 (PMID:31634900).
      N-myristoylation targets FSP1 to the plasma membrane where it reduces CoQ and
      vitamin K to suppress ferroptosis.
    action: ACCEPT
    reason: This is a core localization site for FSP1 function. The plasma membrane
      is where FSP1 regenerates ubiquinol and VKH2 to act as radical-trapping antioxidants.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: myristoylation recruits FSP1 to the plasma membrane where it
        functions as an oxidoreductase that reduces coenzyme Q10
- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: FSP1 is indeed an oxidoreductase - this is its core molecular function.
      However, this term is very general; the more specific term GO:0016655 is preferable.
    action: ACCEPT
    reason: While correct, this general term is subsumed by the more specific GO:0016655
      which precisely describes FSP1&#39;s NAD(P)H-quinone reductase activity. Acceptable
      as a broader classification.
- term:
    id: GO:0022904
    label: respiratory electron transport chain
  evidence_type: IEA
  original_reference_id: GO_REF:0000108
  review:
    summary: This annotation is INCORRECT. FSP1 is NOT part of the mitochondrial respiratory
      electron transport chain. FSP1 reduces quinones at the plasma membrane, not
      in mitochondrial respiration. This appears to be an erroneous inference from
      the electron-transferring-flavoprotein dehydrogenase activity annotation.
    action: REMOVE
    reason: FSP1 does not function in the respiratory electron transport chain. Its
      primary role is reducing ubiquinone and vitamin K at the plasma membrane to
      suppress ferroptosis, which is entirely distinct from mitochondrial respiration.
      This is a false annotation that should be removed.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: myristoylation recruits FSP1 to the plasma membrane where it
        functions as an oxidoreductase that reduces coenzyme Q10
- term:
    id: GO:0031966
    label: mitochondrial membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate of earlier mitochondrial membrane annotation. See previous
      review.
    action: KEEP_AS_NON_CORE
    reason: Mitochondrial membrane is not the primary functional location; plasma
      membrane and lipid droplets are. May represent minor pool or legacy annotation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: This is from a high-throughput binary interactome study. &#34;Protein binding&#34;
      is uninformative per GO curation guidelines.
    action: MARK_AS_OVER_ANNOTATED
    reason: GO:0005515 &#34;protein binding&#34; is considered too vague and uninformative.
      Per curation guidelines, more specific binding terms should be used when available.
      This annotation does not tell us about FSP1&#39;s actual function.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: Here we present a human &#39;all-by-all&#39; reference interactome
        map of human binary protein interactions
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Duplicate annotation - negative regulation of ferroptosis by electronic
      inference. Consistent with experimental evidence.
    action: ACCEPT
    reason: Ferroptosis suppression is the core biological function of FSP1. Electronic
      inference is consistent with extensive experimental evidence.
- term:
    id: GO:1900407
    label: regulation of cellular response to oxidative stress
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: FSP1 regulates oxidative stress response through its role in preventing
      lipid peroxidation. This is consistent with its function as a radical-trapping
      antioxidant regenerator.
    action: ACCEPT
    reason: By regenerating ubiquinol and VKH2, FSP1 prevents lipid peroxidation and
      modulates cellular response to oxidative stress.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: Cytosolic localization confirmed by immunofluorescence (HPA). Consistent
      with FSP1 being a soluble protein that can be recruited to membranes.
    action: ACCEPT
    reason: Cytosolic localization is well-supported and represents the non-membrane-bound
      pool of FSP1.
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:37957306
  review:
    summary: This is the CORRECT and most specific molecular function term for FSP1.
      FSP1 reduces ubiquinone and vitamin K quinones using NAD(P)H as the electron
      donor.
    action: ACCEPT
    reason: This precisely describes FSP1&#39;s core enzymatic activity demonstrated in
      multiple studies (PMID:31634899, PMID:31634900, PMID:35922516, PMID:37957306).
    supported_by:
    - reference_id: PMID:37957306
      supporting_text: Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis
        mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction
        of quinones
- term:
    id: GO:0042373
    label: vitamin K metabolic process
  evidence_type: IDA
  original_reference_id: PMID:36788244
  review:
    summary: FSP1 reduces vitamin K to its hydroquinone form (VKH2), which acts as
      a potent radical-trapping antioxidant. FSP1 is the warfarin-resistant vitamin
      K reductase (PMID:35922516).
    action: ACCEPT
    reason: Vitamin K reduction is a core enzymatic activity of FSP1, demonstrated
      both in vitro and in vivo. FSP1-mediated vitamin K reduction constitutes a non-canonical
      vitamin K cycle for ferroptosis suppression.
    supported_by:
    - reference_id: PMID:35922516
      supporting_text: was found to efficiently reduce vitamin K to its hydroquinone,
        a potent radical-trapping antioxidant and inhibitor of (phospho)lipid peroxidation
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:36788244
  review:
    summary: Ferroptosis suppression via vitamin K reduction pathway. Core function
      with direct experimental evidence.
    action: ACCEPT
    reason: Core biological function of FSP1 with direct experimental support.
    supported_by:
    - reference_id: PMID:36788244
      supporting_text: ferroptosis suppressor protein 1 (FSP1), a ubiquinone oxidoreductase,
        is the enzyme responsible for vitamin K reduction in a warfarin-resistant
        manner
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:37957306
  review:
    summary: Additional experimental evidence for ferroptosis suppression function.
    action: ACCEPT
    reason: Core biological function with direct experimental evidence.
    supported_by:
    - reference_id: PMID:37957306
      supporting_text: Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis
        mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction
        of quinones
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:37739993
  review:
    summary: Core molecular function with experimental evidence.
    action: ACCEPT
    reason: Core enzymatic activity confirmed by direct assay.
    supported_by:
    - reference_id: PMID:37739993
      supporting_text: FSP1 oxidizes NADPH to suppress ferroptosis
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:39160155
  review:
    summary: Core molecular function demonstrated via structural studies showing 6-OH-FAD
      involvement.
    action: ACCEPT
    reason: Core enzymatic activity confirmed by structural analysis.
    supported_by:
    - reference_id: PMID:39160155
      supporting_text: Human ferroptosis suppressor protein 1 (hFSP1), which utilizes
        6-OH-FAD as the primary cofactor, prevents lipid peroxidation by oxidizing
        NAD(P)H
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:40233740
  review:
    summary: Plasma membrane localization confirmed by direct assay. This is a core
      localization site.
    action: ACCEPT
    reason: Core localization for FSP1&#39;s anti-ferroptotic function.
    supported_by:
    - reference_id: PMID:40233740
      supporting_text: ALDH7A1 promotes the membrane recruitment of FSP1
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:31634899
  review:
    summary: This is the landmark paper establishing FSP1&#39;s function as a CoQ reductase.
    action: ACCEPT
    reason: Core enzymatic activity from the discovery paper.
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: FSP1 catalyses the regeneration of CoQ10 using NAD(P)H
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:40233740
  review:
    summary: Core molecular function with experimental evidence from ALDH7A1/FSP1
      study.
    action: ACCEPT
    reason: Core enzymatic activity confirmed.
    supported_by:
    - reference_id: PMID:40233740
      supporting_text: Ferroptosis suppressor protein 1 (FSP1) protects against this
        death by generating antioxidants, which requires nicotinamide adenine dinucleotide,
        reduced form (NADH) as a cofactor
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:31634899
  review:
    summary: Landmark paper establishing FSP1 as a ferroptosis suppressor.
    action: ACCEPT
    reason: Core biological function from the discovery paper.
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: the flavoprotein apoptosis-inducing factor mitochondria-associated
        2 (AIFM2) is a previously unrecognized anti-ferroptotic gene
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:40233740
  review:
    summary: Ferroptosis suppression confirmed in ALDH7A1/FSP1 axis study.
    action: ACCEPT
    reason: Core biological function.
    supported_by:
    - reference_id: PMID:40233740
      supporting_text: Ferroptosis suppressor protein 1 (FSP1) protects against this
        death by generating antioxidants
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:35922516
  review:
    summary: This paper demonstrates FSP1 reduces both ubiquinone and vitamin K using
      NAD(P)H.
    action: ACCEPT
    reason: Core enzymatic activity confirmed for both CoQ and vitamin K substrates.
    supported_by:
    - reference_id: PMID:35922516
      supporting_text: Ferroptosis suppressor protein 1 (FSP1), a NAD(P)H-ubiquinone
        reductase and the second mainstay of ferroptosis control after glutathione
        peroxidase-4
- term:
    id: GO:0042373
    label: vitamin K metabolic process
  evidence_type: IDA
  original_reference_id: PMID:35922516
  review:
    summary: FSP1 is the warfarin-resistant vitamin K reductase in both the non-canonical
      (anti-ferroptotic) and canonical (coagulation) vitamin K cycles.
    action: ACCEPT
    reason: Core enzymatic activity with direct evidence.
    supported_by:
    - reference_id: PMID:35922516
      supporting_text: FSP1 is the enzyme mediating warfarin-resistant vitamin K reduction
        in the canonical vitamin K cycle
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:35922516
  review:
    summary: FSP1-mediated vitamin K reduction constitutes a non-canonical vitamin
      K cycle that suppresses ferroptosis.
    action: ACCEPT
    reason: Core biological function.
    supported_by:
    - reference_id: PMID:35922516
      supporting_text: The FSP1-dependent non-canonical vitamin K cycle can act to
        protect cells against detrimental lipid peroxidation and ferroptosis
- term:
    id: GO:1990748
    label: cellular detoxification
  evidence_type: IDA
  original_reference_id: PMID:35922516
  review:
    summary: By regenerating radical-trapping antioxidants (ubiquinol, VKH2), FSP1
      protects cells from lipid peroxidation, which can be considered a form of detoxification.
    action: ACCEPT
    reason: FSP1&#39;s function in preventing lipid peroxidation represents cellular detoxification
      of lipid radicals.
    supported_by:
    - reference_id: PMID:35922516
      supporting_text: was found to efficiently reduce vitamin K to its hydroquinone,
        a potent radical-trapping antioxidant and inhibitor of (phospho)lipid peroxidation
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: Nuclear localization inferred from mouse ortholog. May occur under oxidative
      stress.
    action: KEEP_AS_NON_CORE
    reason: Not the primary functional location. Nuclear translocation may occur under
      specific stress conditions.
- term:
    id: GO:1900407
    label: regulation of cellular response to oxidative stress
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: FSP1 regulates oxidative stress response through its anti-ferroptotic
      function.
    action: ACCEPT
    reason: Consistent with FSP1&#39;s role in preventing lipid peroxidation.
- term:
    id: GO:0005811
    label: lipid droplet
  evidence_type: IDA
  original_reference_id: PMID:31634900
  review:
    summary: Lipid droplet localization demonstrated in the FSP1 discovery paper.
    action: ACCEPT
    reason: Core localization site for FSP1&#39;s anti-ferroptotic function.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: Together, these results indicate that myristoylation of FSP1
        mediates its recruitment to LDs and the plasma membrane
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:31634900
  review:
    summary: Plasma membrane localization demonstrated in the FSP1 discovery paper.
    action: ACCEPT
    reason: Primary localization site for FSP1&#39;s anti-ferroptotic function.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: myristoylation recruits FSP1 to the plasma membrane where it
        functions as an oxidoreductase that reduces coenzyme Q10
    - reference_id: PMID:38514855
      supporting_text: the deletion of RNF126 reduces the subcellular localization
        of FSP1 in the plasma membrane
- term:
    id: GO:0006743
    label: ubiquinone metabolic process
  evidence_type: IDA
  original_reference_id: PMID:31634899
  review:
    summary: FSP1 reduces ubiquinone to ubiquinol, constituting involvement in CoQ
      metabolism.
    action: ACCEPT
    reason: Core biological process - FSP1 regenerates ubiquinol at the plasma membrane.
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: &#39;the suppression of ferroptosis by FSP1 is mediated by ubiquinone
        (also known as coenzyme Q10, CoQ10): the reduced form, ubiquinol, traps lipid
        peroxyl radicals that mediate lipid peroxidation, whereas FSP1 catalyses the
        regeneration of CoQ10 using NAD(P)H&#39;
- term:
    id: GO:0006743
    label: ubiquinone metabolic process
  evidence_type: IDA
  original_reference_id: PMID:31634900
  review:
    summary: FSP1 as CoQ oxidoreductase - involvement in ubiquinone metabolism.
    action: ACCEPT
    reason: Core biological process.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: myristoylation recruits FSP1 to the plasma membrane where it
        functions as an oxidoreductase that reduces coenzyme Q10 (CoQ) (also known
        as ubiquinone-10)
- term:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:31634900
  review:
    summary: Core molecular function from the companion FSP1 discovery paper.
    action: ACCEPT
    reason: Core enzymatic activity.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
        ferroptosis
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IMP
  original_reference_id: PMID:31634899
  review:
    summary: Ferroptosis suppression demonstrated by mutant phenotype analysis.
    action: ACCEPT
    reason: Core biological function with genetic evidence.
    supported_by:
    - reference_id: PMID:31634899
      supporting_text: AIFM2, which we renamed ferroptosis suppressor protein 1 (FSP1)
        and which was initially described as a pro-apoptotic gene11, confers protection
        against ferroptosis elicited by GPX4 deletion
- term:
    id: GO:0110076
    label: negative regulation of ferroptosis
  evidence_type: IMP
  original_reference_id: PMID:31634900
  review:
    summary: Ferroptosis suppression demonstrated by mutant phenotype analysis.
    action: ACCEPT
    reason: Core biological function with genetic evidence.
    supported_by:
    - reference_id: PMID:31634900
      supporting_text: Together, these findings demonstrate that FSP1 is a strong
        suppressor of ferroptosis
- term:
    id: GO:0005741
    label: mitochondrial outer membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6791306
  review:
    summary: This Reactome annotation relates to TP53-mediated AIFM2 transcription
      in the context of cytochrome C release. The mitochondrial outer membrane localization
      derives from the original AMID characterization, but FSP1&#39;s primary functional
      location is now known to be plasma membrane and lipid droplets.
    action: KEEP_AS_NON_CORE
    reason: Not the primary functional location. The plasma membrane and lipid droplets
      are where FSP1 performs its core anti-ferroptotic function.
- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IDA
  original_reference_id: PMID:11980907
  review:
    summary: This is from the original 2002 AMID characterization showing overexpression-induced
      apoptosis. UniProt explicitly notes conflicting data on this function.
    action: MARK_AS_OVER_ANNOTATED
    reason: Based on overexpression studies before FSP1&#39;s primary function was known.
      Current consensus is that FSP1 suppresses cell death (ferroptosis) rather than
      promoting it. The pro-apoptotic function may be an artifact of overexpression.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: Overexpression of AMID induced cell death with characteristic
        apoptotic morphology
- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: HDA
  original_reference_id: PMID:22664934
  review:
    summary: This annotation is from a tear proteomics study comparing breast cancer
      patients to controls. Extracellular detection may represent secretion or cell
      lysis. This is not a primary functional location.
    action: KEEP_AS_NON_CORE
    reason: Detection in tear fluid does not indicate extracellular space is a primary
      functional location. May be due to cell lysis or non-specific secretion.
    supported_by:
    - reference_id: PMID:22664934
      supporting_text: Over 150 proteins in the tear fluid of CTRL and CA were identified
- term:
    id: GO:0008637
    label: apoptotic mitochondrial changes
  evidence_type: IDA
  original_reference_id: PMID:11980907
  review:
    summary: From the original AMID characterization. The pro-apoptotic function is
      disputed.
    action: KEEP_AS_NON_CORE
    reason: Legacy annotation based on overexpression studies. Not considered a core
      function based on current understanding of FSP1 as a ferroptosis suppressor.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: AMID induces a novel caspase-independent apoptotic pathway
- term:
    id: GO:0005811
    label: lipid droplet
  evidence_type: IDA
  original_reference_id: PMID:14741744
  review:
    summary: Early identification of FSP1/AMID in lipid droplet proteomics from hepatocytes.
    action: ACCEPT
    reason: Lipid droplet localization confirmed by multiple studies. Core localization
      site.
    supported_by:
    - reference_id: PMID:14741744
      supporting_text: 17 major proteins in the fraction were identified using nano
        LC-MS/MS techniques
- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IDA
  original_reference_id: PMID:15958387
  review:
    summary: DNA binding demonstrated biochemically, but lacking sequence specificity.
      Physiological relevance unclear.
    action: KEEP_AS_NON_CORE
    reason: While demonstrated in vitro, DNA binding is not considered a core function
      of FSP1. Its physiological relevance is unclear.
    supported_by:
    - reference_id: PMID:15958387
      supporting_text: AMID is a DNA-binding protein that lacks apparent DNA sequence
        specificity
- term:
    id: GO:0004174
    label: electron-transferring-flavoprotein dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:15958387
  review:
    summary: This term (GO:0004174) specifically refers to electron transfer from
      ETF to ubiquinone in the mitochondrial ETC. FSP1 does not interact with ETF
      and is not part of the respiratory chain. The correct term is GO:0016655.
    action: MODIFY
    reason: GO:0004174 is incorrect - FSP1 reduces quinones directly using NAD(P)H,
      not via ETF. Should be GO:0016655.
    proposed_replacement_terms:
    - id: GO:0016655
      label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
        as acceptor
    supported_by:
    - reference_id: PMID:15958387
      supporting_text: possesses NAD(P)H oxidase activity; and catalyzes NAD(P)H-dependent
        reduction of cytochrome c and other electron acceptors
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IDA
  original_reference_id: PMID:15958387
  review:
    summary: FAD binding (specifically 6-hydroxy-FAD) directly demonstrated biochemically.
    action: ACCEPT
    reason: Core molecular function - FAD binding is essential for FSP1&#39;s oxidoreductase
      activity.
    supported_by:
    - reference_id: PMID:15958387
      supporting_text: AMID binds 6-hydroxy-FAD (a cofactor that accumulates only
        adventitiously and at low abundance in other flavoprotein enzymes) to form
        a stoichiometric cofactor.protein complex
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:12135761
  review:
    summary: Cytoplasmic localization confirmed in the original PRG3 paper.
    action: ACCEPT
    reason: Well-supported localization.
    supported_by:
    - reference_id: PMID:12135761
      supporting_text: PRG3 localizes in the cytoplasm
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:11980907
  review:
    summary: Mitochondrial localization from the original AMID paper. Current understanding
      indicates plasma membrane and lipid droplets are the primary functional sites.
    action: KEEP_AS_NON_CORE
    reason: While some mitochondrial localization was reported, the primary functional
      locations are plasma membrane and lipid droplets. The name &#34;AMID&#34; (mitochondrion-
      associated) reflects the original characterization but not current understanding.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: Immunofluorescent staining and biochemical experiments indicated
        that AMID was co-localized with mitochondria
- term:
    id: GO:0005741
    label: mitochondrial outer membrane
  evidence_type: IDA
  original_reference_id: PMID:11980907
  review:
    summary: Mitochondrial outer membrane localization from original AMID paper.
    action: KEEP_AS_NON_CORE
    reason: Not the primary functional location based on current understanding.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: Immunofluorescent staining and biochemical experiments indicated
        that AMID was co-localized with mitochondria
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: PMID:11980907
  review:
    summary: Cytosolic localization confirmed.
    action: ACCEPT
    reason: Cytosolic localization is well-supported.
    supported_by:
    - reference_id: PMID:11980907
      supporting_text: AMID lacks a mitochondrial localization sequence but shares
        significant homology with AIF and NADH oxidoreductases
references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000108
  title: Automatic assignment of GO terms using logical inference, based on on inter-ontology
    links
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:11980907
  title: AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein,
    induces caspase-independent apoptosis.
  findings: []
- id: PMID:12135761
  title: A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the
    apoptosis-inducing factor (AIF).
  findings: []
- id: PMID:14741744
  title: Identification of major proteins in the lipid droplet-enriched fraction isolated
    from the human hepatocyte cell line HuH7.
  findings: []
- id: PMID:15958387
  title: The human apoptosis-inducing protein AMID is an oxidoreductase with a modified
    flavin cofactor and DNA binding activity.
  findings: []
- id: PMID:22664934
  title: Comparison of tear protein levels in breast cancer patients and healthy controls
    using a de novo proteomic approach.
  findings: []
- id: PMID:31634899
  title: FSP1 is a glutathione-independent ferroptosis suppressor.
  findings: []
- id: PMID:31634900
  title: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
  findings: []
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
- id: PMID:35922516
  title: A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
  findings: []
- id: PMID:36788244
  title: A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant
    vitamin K reductase.
  findings: []
- id: PMID:37739993
  title: FSP1 oxidizes NADPH to suppress ferroptosis.
  findings: []
- id: PMID:37957306
  title: Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis
    regulation.
  findings: []
- id: PMID:39160155
  title: Structural insight into 6-OH-FAD-dependent activation of hFSP1 for ferroptosis
    suppression.
  findings: []
- id: PMID:40233740
  title: ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating
    FSP1.
  findings: []
- id: PMID:38514855
  title: RNF126-mediated ubiquitination of FSP1 affects its subcellular localization
    and ferroptosis.
  findings:
  - statement: RNF126 acts as an anti-ferroptotic gene by interacting with FSP1 and
      ubiquitinating FSP1 at the 4KR-2 sites
    supporting_text: RNF126 acts as an anti-ferroptotic gene by interacting with
      ferroptosis suppressor protein 1 (FSP1, also known as AIFM2) and ubiquitinating
      FSP1 at the 4KR-2 sites
  - statement: RNF126 deletion reduces plasma membrane localization of FSP1 and increases
      the CoQ/CoQH2 ratio
    supporting_text: the deletion of RNF126 reduces the subcellular localization
      of FSP1 in the plasma membrane, resulting in an increase in the CoQ/CoQH2 ratio
  - statement: The RNF126-FSP1-CoQ10 pathway suppresses phospholipid peroxidation and
      ferroptosis in vivo and in vitro
    supporting_text: The RNF126-FSP1-CoQ10 pathway plays a pivotal role in suppressing
      phospholipid peroxidation and ferroptosis both in vivo and in vitro
- id: PMID:39313331
  title: Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain
    liver cancer progression.
  findings:
  - statement: Temsirolimus sensitizes liver cancer cells to ferroptosis by directly
      binding to and inhibiting FSP1 enzyme activity
    supporting_text: temsirolimus sensitized liver cancer cells to ferroptosis by
      directly binding to and inhibiting ferroptosis suppressor protein 1 (FSP1)
      enzyme
  - statement: Temsirolimus-induced ferroptosis is primarily attributed to FSP1 inhibition
      rather than mTOR activity
    supporting_text: while temsirolimus is recognized as a potent mammalian target
      of rapamycin (mTOR) inhibitor, its ferroptosis-inducing effect is primarily
      attributed to the inhibition of FSP1 rather than mTOR activity
  - statement: The combination of temsirolimus and RSL3 suppresses liver tumor progression
      and is associated with increased lipid peroxidation and ferroptosis
    supporting_text: the combination of temsirolimus and RSL3 effectively suppressed
      liver tumor progression. This tumoricidal effect was associated with increased
      lipid peroxidation and induction of ferroptosis
- id: Reactome:R-HSA-6791306
  title: TP53 stimulates AIFM2 gene expression
  findings: []
- id: file:human/AIFM2/AIFM2-deep-research-falcon.md
  title: Deep research on AIFM2/FSP1 function
  findings: []
- id: file:human/AIFM2/AIFM2-deep-research-cyberian.md
  title: Comprehensive deep research on AIFM2/FSP1 including structural insights, regulatory
    mechanisms, and therapeutic implications
  findings:
  - statement: FSP1 forms a functional homodimer with a unique 25-degree rotation of
      the FAD isoalloxazine ring; the C-terminal domain mediates dimerization essential
      for catalytic activity
    supporting_text: The carboxy-terminal domain mediates functional dimerization of
      FSP1, forming a homodimer that is required for the assembly of FAD- and ubiquinone-binding
      pockets and for catalytic activity [lv-2023-structural-insights-abstract]. A
      unique feature of FSP1 structure is the ~25-degree rotation of the FAD isoalloxazine
      ring compared to all other known FAD-dependent oxidoreductases [lv-2023-structural-insights-abstract].
  - statement: FSP1 generates 6-hydroxy-FAD which is both an active cofactor and an
      anti-ferroptotic compound
    supporting_text: This 6-hydroxy-FAD was identified as both an active cofactor of
      FSP1 and a potent anti-ferroptotic compound in its own right, adding another
      layer to FSP1&#39;s ferroptosis-suppressing mechanisms [lv-2023-structural-insights-abstract].
  - statement: FSP1 promotes ESCRT-III-dependent membrane repair by recruiting CHMP5
      and CHMP6, independent of its enzymatic activity
    supporting_text: FSP1 has been shown to potentiate the recruitment of ESCRT-III
      subunits CHMP5 and CHMP6 to the plasma membrane following ferroptosis-inducing
      stress. This pathway operates independently of CoQ10, suggesting that FSP1 has
      functions beyond its enzymatic activity.
  - statement: FSP1 expression is regulated by the KEAP1-NRF2 pathway; two AREs in
      the FSP1 promoter bind NRF2
    supporting_text: FSP1 expression is regulated at the transcriptional level by
      several pathways, most notably the KEAP1-NRF2 antioxidant response pathway.
      Two antioxidant response elements (AREs), which are canonical NRF2 binding motifs,
      have been identified in the FSP1 promoter region, and ChIP-qPCR assays confirmed
      increased NRF2 binding to these AREs upon KEAP1 knockout.
  - statement: KEAP1 mutations in NSCLC lead to elevated FSP1 expression and ferroptosis/radiation
      resistance
    supporting_text: Consequently, KEAP1 mutations, which are common in non-small cell
      lung cancer (NSCLC), lead to constitutive NRF2 activation and elevated FSP1
      expression, contributing to ferroptosis and radiation resistance [koppula-2022-coq-fsp1-abstract].
  - statement: icFSP1 (3-phenylquinazolinone) induces FSP1 phase separation and condensate
      formation, displacing it from membranes
    supporting_text: icFSP1 promotes FSP1 phase separation and condensate formation,
      displacing FSP1 from membranes and thereby preventing its anti-ferroptotic function
      [nakamura-2023-phase-separation-abstract].
  - statement: FSP1 also localizes to lipid droplet periphery where it prevents neutral
      lipid peroxidation
    supporting_text: Beyond the plasma membrane, FSP1 also localizes to the periphery
      of lipid droplets (LDs) [nakamura-2023-phase-separation-abstract]. Recent work
      has revealed that LD-localized FSP1 plays a critical role in preventing neutral
      lipid peroxidation.
  - statement: iFSP1 is human-specific; F360 is essential for binding (differs from
      murine FSP1)
    supporting_text: Notably, iFSP1 is human-specific and does not effectively inhibit
      murine FSP1 due to species differences in an aromatic pocket, with F360 of human
      FSP1 being essential for iFSP1 binding [dasilva-2023-ifsp1-inhibition-abstract].
- id: PMID:37380771
  title: Phase separation of FSP1 promotes ferroptosis
  findings:
  - statement: icFSP1 promotes FSP1 phase separation and condensate formation, displacing
      FSP1 from membranes
    supporting_text: We show that icFSP1, unlike iFSP1, the first described on-target
      FSP1 inhibitor5, does not competitively inhibit FSP1 enzyme activity, but
      instead triggers subcellular relocalization of FSP1 from the membrane and
      FSP1 condensation before ferroptosis induction, in synergism with GPX4 inhibition
  - statement: This mechanism requires N-terminal myristoylation and intrinsically
      disordered regions
    supporting_text: N-terminal myristoylation, distinct amino acid residues and
      intrinsically disordered, low-complexity regions in FSP1 were identified to
      be essential for FSP1-dependent phase separation in cells and in vitro
  - statement: icFSP1 impairs tumor growth in vivo and induces FSP1 condensates within
      tumors
    supporting_text: icFSP1 impairs tumour growth and induces FSP1 condensates in
      tumours in vivo
- id: PMID:37739943
  title: Structural insights into FSP1 catalysis and ferroptosis inhibition
  findings:
  - statement: Crystal structures of Gallus gallus FSP1 at 2.0A (substrate-free) and
      2.6A (ubiquinone-bound)
    supporting_text: We report the crystal structures of cFSP1 (residues 12‚Äì373,
      hereafter named cFSP1ŒîN) in its substrate-free and ubiquinone (CoQ1)-bound
      forms at 2.0 and 2.6‚Äâ√Ö resolution
  - statement: FSP1 contains FAD-binding domain, NAD(P)H-binding domain, and C-terminal
      dimerization domain
    supporting_text: The structures reveal a FAD-binding domain and a NAD(P)H-binding
      domain, both of which are shared with AIF and NADH oxidoreductases4-9, and
      a characteristic carboxy-terminal domain as well
  - statement: Unique 25-degree rotation of FAD isoalloxazine ring compared to other
      FAD-dependent oxidoreductases
    supporting_text: the isoalloxazine ring of the FAD in cFSP1 rotates ~ 25 degrees
      compared with that in all known structures of other FAD-dependent oxidoreductases
  - statement: 6-hydroxy-FAD identified as both active cofactor and anti-ferroptotic
      compound
    supporting_text: identify that FSP1 can catalyze the production of H2O2 and the
      conversion of FAD to 6-hydroxy-FAD in the presence of oxygen and NAD(P)H in
      vitro, and 6-hydroxy-FAD directly inhibits ferroptosis in cells
- id: PMID:35459868
  title: A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in
    KEAP1 inactive lung cancers
  findings:
  - statement: FSP1 expression is elevated in KEAP1-mutant lung cancers
    supporting_text: KEAP1 mutation or deficiency in lung cancer cells upregulates
      FSP1 expression through NRF2
  - statement: CoQ-FSP1 axis contributes to ferroptosis and radiation resistance
    supporting_text: the ubiquinone (CoQ)-FSP1 axis mediates ferroptosis- and radiation-
      resistance in KEAP1 deficient lung cancer cells
  - statement: KEAP1 mutations lead to NRF2 activation and FSP1 upregulation
    supporting_text: In this study, we identify ferroptosis suppressor protein 1
      (FSP1, also known as AIFM2) as a transcriptional target of nuclear factor
      erythroid 2-related factor 2 (NRF2) and reveal that the ubiquinone (CoQ)-FSP1
      axis mediates ferroptosis- and radiation- resistance in KEAP1 deficient lung
      cancer cells
- id: PMID:36264074
  title: FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance
    in lung cancers
  findings:
  - statement: Two antioxidant response elements (AREs) identified in FSP1 promoter
    supporting_text: two antioxidant response elements (AREs) which are well-established
      NRF2 binding motif were found in FSP1 gene promoter regions
  - statement: NRF2 directly binds FSP1 promoter confirmed by ChIP-qPCR
    supporting_text: ChIP-qPCR assay was performed to verify the increased binding
      of NRF2 to the AREs of FSP1 upon KEAP1 knockout
  - statement: NRF2 activation upregulates FSP1 expression
    supporting_text: suggesting the indispensable role of NRF2 in the regulation
      of FSP1 expression and ferroptosis sensitivity
- id: PMID:37080964
  title: Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules
  findings:
  - statement: iFSP1 shows species-specific inhibition on the human isoform
    supporting_text: explore the species-specific inhibition of iFSP1 on the human
      isoform to gain insights into its mechanism of action
  - statement: Species-specific aromatic architecture is essential for target engagement
    supporting_text: establish a critical contribution of a species-specific aromatic
      architecture that is essential for target engagement
  - statement: Caution is warranted when using iFSP1 in murine models
    supporting_text: pose a cautionary notice for using iFSP1 in animal models, specifically
      murine models
core_functions:
- description: FSP1 is the major glutathione-independent ferroptosis suppressor, operating
    in parallel to GPX4. Demonstrated by genetic deletion and overexpression studies
    in multiple cell types and in vivo models.
  molecular_function:
    id: GO:0016655
    label: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound
      as acceptor
  directly_involved_in:
  - id: GO:0110076
    label: negative regulation of ferroptosis
  - id: GO:0006743
    label: ubiquinone metabolic process
  - id: GO:0042373
    label: vitamin K metabolic process
  locations:
  - id: GO:0005886
    label: plasma membrane
  - id: GO:0005811
    label: lipid droplet
proposed_new_terms: []
suggested_questions:
- question: What is the physiological relevance of FSP1&#39;s DNA binding activity, and
    is it relevant to the original pro-apoptotic observations?
- question: What determines FSP1&#39;s distribution between plasma membrane and lipid
    droplets, and what are the regulatory mechanisms for partitioning?
- question: Does FSP1 have substrate specificity for different quinone species, and
    what are the relative affinities and physiological relevance of each substrate?
suggested_experiments:
- description: Membrane fractionation with FSP1 activity assays to determine the relative
    contribution of plasma membrane vs lipid droplet pools to overall FSP1 function.
  hypothesis: Plasma membrane-localized FSP1 provides the majority of ferroptosis
    protection under normal conditions, while lipid droplet-localized FSP1 may be
    more important under lipotoxic stress.
- description: Kinetic comparison of FSP1 activity toward CoQ vs vitamin K substrates
    under different conditions to establish physiological substrate preferences.
  hypothesis: FSP1 preferentially reduces CoQ under normal conditions but may switch
    to vitamin K reduction when CoQ is limiting or under specific stress conditions.
tags:
- ferroptosis
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>